Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 716 articles:
HTML format
Text format



Single Articles


    September 2018
  1. LAWSON CA, Testani JM, Mamas M, Damman K, et al
    Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study.
    Int J Cardiol. 2018;267:120-127.
    PubMed     Text format     Abstract available


  2. JANG SY, Chae SC, Bae MH, Lee JH, et al
    Effect of renin-angiotensin system blockade in patients with severe renal insufficiency and heart failure.
    Int J Cardiol. 2018;266:180-186.
    PubMed     Text format     Abstract available


  3. LEMOR A, Hernandez GA, Lee S, Patel N, et al
    Impact of end stage renal disease on in-hospital outcomes of patients with systolic and diastolic heart failure (insights from the Nationwide Inpatient Sample 2010 to 2014).
    Int J Cardiol. 2018;266:174-179.
    PubMed     Text format     Abstract available


  4. RIENSTRA M, van Veldhuisen DJ
    Atrial fibrillation is more troublesome in heart failure patients with preserved compared to those with reduced ejection fraction.
    Int J Cardiol. 2018;266:155-156.
    PubMed     Text format    


  5. GOYAL P, Almarzooq ZI, Cheung J, Kamel H, et al
    Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.
    Int J Cardiol. 2018;266:112-118.
    PubMed     Text format     Abstract available


    August 2018
  6. BUONO A, Oliva F, Ammirati E
    Reduction of heart rate in patients with heart failure aiming to improve ventricular-arterial coupling.
    Int J Cardiol. 2018;265:172.
    PubMed     Text format    


  7. GUARRACINO F, Bertini P
    Heart rate control or tailored heart rate to improve ventriculo-arterial coupling in heart failure?
    Int J Cardiol. 2018;265:171.
    PubMed     Text format    


  8. EMDIN M, Aimo A, Mirizzi G, Piacenti M, et al
    Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox.
    Int J Cardiol. 2018;265:169-170.
    PubMed     Text format    


  9. SHI V, Senni M, Streefkerk H, Modgill V, et al
    Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study.
    Int J Cardiol. 2018;264:118-123.
    PubMed     Text format     Abstract available


    July 2018
  10. CHOU CH, Fu TC, Tsai HH, Hsu CC, et al
    High-intensity interval training enhances mitochondrial bioenergetics of platelets in patients with heart failure.
    Int J Cardiol. 2018 Jul 27. pii: S0167-5273(18)30650.
    PubMed     Text format     Abstract available


  11. SADANAGA T
    Are serial measurements of plasma concentrations of natriuretic peptide useful in real-world practice in patients with heart failure?
    Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)33973.
    PubMed     Text format    


  12. POPOVIC B, Zannad F, Louis H, Clerc-Urmes I, et al
    Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure.
    Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)31193.
    PubMed     Text format     Abstract available


  13. AIMO A, Januzzi JL Jr, Vergaro G, Petersen C, et al
    Left ventricular ejection fraction for risk stratification in chronic systolic heart failure.
    Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)32001.
    PubMed     Text format     Abstract available


  14. SMITH ED, Tome J, Mcgrath R, Kumar S, et al
    Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death.
    Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)33053.
    PubMed     Text format     Abstract available


  15. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, de Miguel-Yanes JM, et al
    Influence of COPD on outcomes of patients hospitalized with heart failure: Analysis of the Spanish National Hospital Discharge Database (2001-2015).
    Int J Cardiol. 2018 Jul 17. pii: S0167-5273(18)33503.
    PubMed     Text format     Abstract available


  16. ANGELI F, Reboldi G, Verdecchia P
    Heart failure, pulse pressure and heart rate: Refining risk stratification.
    Int J Cardiol. 2018 Jul 17. pii: S0167-5273(18)34171.
    PubMed     Text format    


  17. GRONDA E, Sacchi S, Vanoli E
    Corrigendum to "Letter to correlation between pulmonary artery pressure and thoracic impedance: Insights from dailymonitoring through an implanted device in chronic heart failure" [Int. J. Cardiol. 245 (2017) 196-200].
    Int J Cardiol. 2018 Jul 16. pii: S0167-5273(18)34336.
    PubMed     Text format    


  18. COSENTINO N, Campodonico J
    Acute heart failure: Diagnosis first and then treatment.
    Int J Cardiol. 2018 Jul 6. pii: S0167-5273(18)34155.
    PubMed     Text format    


  19. ANDO G, Manganaro R
    Change in natremia as a prognostic marker in patients with acute heart failure.
    Int J Cardiol. 2018 Jul 6. pii: S0167-5273(18)33972.
    PubMed     Text format    


  20. KHEIRI B, Osman M, Abdalla A, Haykal T, et al
    Catheter ablation of atrial fibrillation with heart failure: An updated meta-analysis of randomized trials.
    Int J Cardiol. 2018 Jul 4. pii: S0167-5273(18)32169.
    PubMed     Text format     Abstract available


    June 2018
  21. WARD MJ, Collins SP, Liu D, Froehle CM, et al
    Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure.
    Int J Cardiol. 2018 Jun 28. pii: S0167-5273(18)31624.
    PubMed     Text format     Abstract available


  22. ZHANG J, Pellicori P, Pan D, Dierckx R, et al
    Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure.
    Int J Cardiol. 2018 Jun 25. pii: S0167-5273(17)37429.
    PubMed     Text format     Abstract available


  23. PERSSON H, Donal E, Lund LH, Matan D, et al
    Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) study.
    Int J Cardiol. 2018 Jun 20. pii: S0167-5273(17)33799.
    PubMed     Text format     Abstract available


  24. ARIZA-SOLE A, Guerrero C, Formiga F
    Bayes syndrome: Improving risk stratification in chronic heart failure?
    Int J Cardiol. 2018 Jun 18. pii: S0167-5273(18)33213.
    PubMed     Text format    


  25. WANG JS
    Effect of exercise training on exercise capacity and quality of life in patients with heart failure.
    Int J Cardiol. 2018;261:144-145.
    PubMed     Text format    


  26. OLCHANSKI N, Vest AR, Cohen JT, Neumann PJ, et al
    Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions.
    Int J Cardiol. 2018;261:103-108.
    PubMed     Text format     Abstract available


  27. RINALDI CA
    Cardiac resynchronization therapy consensus guidelines: Evolution or revolution?
    Int J Cardiol. 2018;261:142-143.
    PubMed     Text format    


  28. ICHIKI T, Dzhoyashvili N, Burnett JC Jr
    Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide.
    Int J Cardiol. 2018 Jun 3. pii: S0167-5273(18)32660.
    PubMed     Text format     Abstract available


  29. DOCHERTY KF, McMurray JJV
    Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)31989.
    PubMed     Text format     Abstract available


  30. LORENZONI G, Azzolina D, Lanera C, Brianti G, et al
    Time trends in first hospitalization for heart failure in a community-based population.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(17)36730.
    PubMed     Text format     Abstract available


  31. EGOM EE, Maher V, El Hiani Y
    Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30187.
    PubMed     Text format     Abstract available


  32. COSTANTINO S, Paneni F
    Stem cell therapy in heart failure: Is the best yet to come?
    Int J Cardiol. 2018;260:135-136.
    PubMed     Text format    


  33. BANOVIC M, Pusnik-Vrckovnik M, Nakou E, Vardas P, et al
    Myocardial regeneration therapy in heart failure: Current status and future therapeutic implications in clinical practice.
    Int J Cardiol. 2018;260:124-130.
    PubMed     Text format     Abstract available


  34. LOPATIN YM, Cowie MR, Grebennikova AA, Sisakian HS, et al
    Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program.
    Int J Cardiol. 2018;260:113-117.
    PubMed     Text format     Abstract available


  35. STEWART COATS AJ
    Heart rate as a target: Ready for pole position?
    Int J Cardiol. 2018;260:131-132.
    PubMed     Text format    


  36. SADANAGA T
    Can we "ScREEN" response to cardiac resynchronization therapy by a simple score?
    Int J Cardiol. 2018;260:105-106.
    PubMed     Text format    


    May 2018
  37. SHAH P, Pellicori P, Rimmer S, Rigby AS, et al
    Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction.
    Int J Cardiol. 2018 May 23. pii: S0167-5273(17)37345.
    PubMed     Text format     Abstract available


  38. PASSINO C, Aimo A, Emdin M, Vergaro G, et al
    Quality of life and outcome in heart failure with preserved ejection fraction: When sex matters.
    Int J Cardiol. 2018 May 23. pii: S0167-5273(18)32629.
    PubMed     Text format    


  39. VERGARO G, Iacoviello M
    Is there a "renal paradox" in chronic heart failure?
    Int J Cardiol. 2018 May 23. pii: S0167-5273(18)32731.
    PubMed     Text format    


  40. SHULMAN E, Shah T, Mazori AY, Chudow JJ, et al
    Heart failure and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.
    Int J Cardiol. 2018 May 22. pii: S0167-5273(17)37213.
    PubMed     Text format    


  41. YU Z, Chen R, Li M, Yu Y, et al
    Mitochondrial calcium uniporter inhibition provides cardioprotection in pressure overload-induced heart failure through autophagy enhancement.
    Int J Cardiol. 2018 May 20. pii: S0167-5273(17)37641.
    PubMed     Text format     Abstract available


  42. ESCOBAR-ROBLEDO LA, Bayes-de-Luna A, Lupon J, Baranchuk A, et al
    Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The "Bayes' Syndrome-HF" study.
    Int J Cardiol. 2018 May 18. pii: S0167-5273(18)31019.
    PubMed     Text format     Abstract available


  43. SUTHERLAND N, Harrison A, Doherty P
    Factors influencing change in walking ability in patients with heart failure undergoing exercise-based cardiac rehabilitation.
    Int J Cardiol. 2018 May 17. pii: S0167-5273(17)36944.
    PubMed     Text format     Abstract available


  44. DILAVERIS P, Tousoulis D
    Big data analysis from Sweden confirms that resting heart rate in late adolescence is significantly associated with incident heart failure and all-cause mortality.
    Int J Cardiol. 2018;259:220-221.
    PubMed     Text format    


  45. GRONDA E, Sacchi S, Vanoli E
    Letter to "Correlation between pulmonary artery pressure and thoracic impedance: Insights from daily monitoring through an implanted device in chronic heart failure".
    Int J Cardiol. 2018;259:185.
    PubMed     Text format    


  46. MUNTEAN I, Benedek T, Toganel R
    Right ventriculo-arterial coupling in heart failure - Is the right ventricle independent?
    Int J Cardiol. 2018;259:136.
    PubMed     Text format    


  47. IACOVIELLO M, Monitillo F, Citarelli G, Grande D, et al
    Right ventriculo-arterial coupling in heart failure: The role of the interventricular septum.
    Int J Cardiol. 2018;259:134-135.
    PubMed     Text format    


  48. PEREGO GB
    Why is PAP guided therapy effective?
    Int J Cardiol. 2018;259:137.
    PubMed     Text format    


  49. WANG R, Liu X, Schoepf UJ, van Assen M, et al
    Extracellular volume quantitation using dual-energy CT in patients with heart failure: Comparison with 3T cardiac MR.
    Int J Cardiol. 2018 May 10. pii: S0167-5273(18)30174.
    PubMed     Text format     Abstract available


  50. HORIUCHI Y, Tanimoto S, Aoki J, Fuse N, et al
    Corrigendum to "Mismatch between right- and left-sided filling pressures in heart failure patients with preserved ejection fraction" [Int. J. Cardiol. 257 (2018) 143-149].
    Int J Cardiol. 2018 May 3. pii: S0167-5273(18)32612.
    PubMed     Text format    


  51. VALBUSA F, Agnoletti D, Scala L, Grillo C, et al
    Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure.
    Int J Cardiol. 2018 May 2. pii: S0167-5273(18)30544.
    PubMed     Text format     Abstract available


  52. AIMO A, Vergaro G, Giannoni A, Emdin M, et al
    Wet is bad: Residual congestion predicts worse prognosis in acute heart failure.
    Int J Cardiol. 2018;258:201-202.
    PubMed     Text format    


  53. RUBIO-GRACIA J, Demissei BG, Ter Maaten JM, Cleland JG, et al
    Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.
    Int J Cardiol. 2018;258:185-191.
    PubMed     Text format     Abstract available


  54. TAKAHAMA H, Takashio S, Nishikimi T, Hayashi T, et al
    Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
    Int J Cardiol. 2018;258:165-171.
    PubMed     Text format     Abstract available


  55. NOWAK A, Siegenthaler M, Namdar M, Ruschitzka F, et al
    Reply: Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up.
    Int J Cardiol. 2018;258:206.
    PubMed     Text format    


  56. KAWADA T
    Prognostic effect of cardio-renal syndrome in patients with Fabry disease.
    Int J Cardiol. 2018;258:205.
    PubMed     Text format    


    April 2018
  57. SILLER-MATULA JM, Pecen L, Patti G, Lucerna M, et al
    Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
    Int J Cardiol. 2018 Apr 22. pii: S0167-5273(17)37365.
    PubMed     Text format     Abstract available


  58. OLIVARI Z, Giacomelli S, Gubian L, Mancin S, et al
    Erratum to "The effectiveness of remote monitoring of elderly patients after hospitalisation for heart failure: The renewing health European project" [Int. J. Cardiol. 257 (2018) 137-142].
    Int J Cardiol. 2018 Apr 21. pii: S0167-5273(18)32313.
    PubMed     Text format    


  59. HALBACH M, Abraham WT, Butter C, Ducharme A, et al
    Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
    Int J Cardiol. 2018 Apr 21. pii: S0167-5273(18)31351.
    PubMed     Text format     Abstract available


  60. BAI J, Shen D, Wang B, Han Q, et al
    Could the CHA2DS2-VASc schema help stratify risk of ischemic stroke for individual patients with congestive heart failure?
    Int J Cardiol. 2018;257:226.
    PubMed     Text format    


  61. JHUND PS
    Analysing registries in heart failure: The case of angiotensin receptor blockers in Asians with heart failure with reduced ejection fraction.
    Int J Cardiol. 2018;257:224-225.
    PubMed     Text format    


  62. GALDERISI M, Santoro C, Esposito R
    Left atrial function and dyssynchrony: Main characters and not actor appearances in heart failure with preserved ejection fraction.
    Int J Cardiol. 2018;257:222-223.
    PubMed     Text format    


  63. REDDY YNV, Borlaug BA
    When right is wrong in heart failure with preserved ejection fraction.
    Int J Cardiol. 2018;257:216-217.
    PubMed     Text format    


  64. AGBOR VN, Essouma M, Ntusi NAB, Nyaga UF, et al
    Heart failure in sub-Saharan Africa: A contemporaneous systematic review and meta-analysis.
    Int J Cardiol. 2018;257:207-215.
    PubMed     Text format     Abstract available


  65. LIU S, Guan Z, Zheng X, Meng P, et al
    Impaired left atrial systolic function and inter-atrial dyssynchrony may contribute to symptoms of heart failure with preserved left ventricular ejection fraction: A comprehensive assessment by echocardiography.
    Int J Cardiol. 2018;257:177-181.
    PubMed     Text format     Abstract available


  66. CHOI KH, Lee GY, Choi JO, Jeon ES, et al
    Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.
    Int J Cardiol. 2018;257:168-176.
    PubMed     Text format     Abstract available


  67. HORIUCHI Y, Tanimoto S, Aoki J, Fuse N, et al
    Mismatch between right- and left-sided filling pressures in heart failure patients with preserved ejection fraction.
    Int J Cardiol. 2018;257:143-149.
    PubMed     Text format     Abstract available


  68. OLIVARI Z, Giacomelli S, Gubian L, Mancin S, et al
    The effectiveness of remote monitoring of elderly patients after hospitalisation for heart failure: The renewing health European project.
    Int J Cardiol. 2018;257:137-142.
    PubMed     Text format    


  69. WEBB J, Draper J, Rua T, Yiu Y, et al
    A cost effectiveness study establishing the impact and accuracy of implementing the NICE guidelines lowering plasma NTproBNP threshold in patients with clinically suspected heart failure at our institution.
    Int J Cardiol. 2018;257:131-136.
    PubMed     Text format     Abstract available


  70. CAI A, Zhang J, Wang R, Chen J, et al
    Joint effects of obstructive sleep apnea and resistant hypertension on chronic heart failure: A cross-sectional study.
    Int J Cardiol. 2018;257:125-130.
    PubMed     Text format     Abstract available


  71. BAKY V, Moran D, Warwick T, George A, et al
    Obtaining a follow-up appointment before discharge protects against readmission for patients with acute coronary syndrome and heart failure: A quality improvement project.
    Int J Cardiol. 2018;257:12-15.
    PubMed     Text format     Abstract available


  72. PAREN P, Dahlstrom U, Edner M, Lappas G, et al
    Association of diuretic treatment at hospital discharge in patients with heart failure with all-cause short- and long-term mortality: A propensity score-matched analysis from SwedeHF.
    Int J Cardiol. 2018;257:118-124.
    PubMed     Text format     Abstract available


  73. AZADANI PN, Marrouche NF, Wilson BD
    Left atrial fibrosis provides a new means of identifying patients with higher risk of new-onset heart failure among patients with atrial fibrillation.
    Int J Cardiol. 2018;257:113-114.
    PubMed     Text format    


  74. DENG Y, Qin F, Liu Q, Wu Z, et al
    Left atrial fibrosis provides a new means of identifying patients with higher risk of new-onset heart failure among patients with atrial fibrillation.
    Int J Cardiol. 2018;257:110.
    PubMed     Text format    


  75. SPARTALIS M, Tzatzaki E, Doulamis IP, Spartalis E, et al
    T1-mapping provides superior diagnostic accuracy than late gadolinium enhancement imaging in patients with acute myocarditis.
    Int J Cardiol. 2018;257:341.
    PubMed     Text format    


  76. AMMIRATI E, Sormani P, Moroni F, Camici PG, et al
    Changes of late gadolinium enhancement extension compared with native T1 mapping early after acute myocarditis.
    Int J Cardiol. 2018;257:227.
    PubMed     Text format    


  77. KHAN MS, Siddiqi TJ, Usman MS, Sreenivasan J, et al
    Does natriuretic peptide monitoring improve outcomes in heart failure patients? A systematic review and meta-analysis.
    Int J Cardiol. 2018 Apr 12. pii: S0167-5273(18)31346.
    PubMed     Text format     Abstract available


  78. TSUJIMOTO T, Kajio H
    Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction.
    Int J Cardiol. 2018 Apr 9. pii: S0167-5273(17)37109.
    PubMed     Text format     Abstract available


  79. IZUMIYA Y, Hanatani S, Onoue Y, Tsujita K, et al
    Reply to letter to the editor: "A simple sarcopenia screening test predicts future adverse events in patients with heart failure".
    Int J Cardiol. 2018;256:28.
    PubMed     Text format    


  80. SASAKI K, Kataoka T
    Letter to the editor: A simple sarcopenia screening test predicts future adverse events in patients with heart failure.
    Int J Cardiol. 2018;256:27.
    PubMed     Text format    


  81. IWAKAMI N, Nagai T, Furukawa TA, Anzai T, et al
    Response to letter regarding article by Formiga et al., "Utility of the Controlling Nutritional Status (CONUT) score in patients admitted due to acute heart failure".
    Int J Cardiol. 2018;256:25.
    PubMed     Text format    


    March 2018
  82. HORIUCHI Y, Tanimoto S, Latif AHMM, Urayama KY, et al
    Identifying novel phenotypes of acute heart failure using cluster analysis of clinical variables.
    Int J Cardiol. 2018 Mar 29. pii: S0167-5273(17)34849.
    PubMed     Text format     Abstract available


  83. ABEYA FC, Lumori BAE, Akello SJ, Annex BH, et al
    Incidence and predictors of 6months mortality after an acute heart failure event in rural Uganda: The Mbarara Heart Failure Registry (MAHFER).
    Int J Cardiol. 2018 Mar 29. pii: S0167-5273(17)37111.
    PubMed     Text format     Abstract available


  84. SAVARESE G, Donal E, Hage C, Oger E, et al
    Corrigendum to "Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study" [Int. J. Cardiol. 226 (2017) 65-70].
    Int J Cardiol. 2018 Mar 27. pii: S0167-5273(18)31715.
    PubMed     Text format    


  85. SZE S, Pellicori P, Kamzi S, Anton A, et al
    Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure.
    Int J Cardiol. 2018 Mar 22. pii: S0167-5273(17)37814.
    PubMed     Text format     Abstract available


  86. AIMO A, Vergaro G, Barison A, Maffei S, et al
    Sex-related differences in chronic heart failure.
    Int J Cardiol. 2018;255:145-151.
    PubMed     Text format     Abstract available


  87. CHOY JS, Leng S, Acevedo-Bolton G, Shaul S, et al
    Efficacy of intramyocardial injection of Algisyl-LVR for the treatment of ischemic heart failure in swine.
    Int J Cardiol. 2018;255:129-135.
    PubMed     Text format     Abstract available


  88. DEIDDA M, Cadeddu Dessalvi C, Mercuro G
    The need of a gender-corrected evidence based medicine.
    Int J Cardiol. 2018;255:156-157.
    PubMed     Text format    


  89. MORONI F, Castelvecchio S, Menicanti L
    Reshaping the failing heart: One step forward in elucidating the role of biomaterials in preventing cardiac remodeling.
    Int J Cardiol. 2018;255:152-153.
    PubMed     Text format    


  90. POTOCNJAK I, Radulovic B, Degoricija V, Trbusic M, et al
    Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients.
    Int J Cardiol. 2018 Mar 11. pii: S0167-5273(17)36901.
    PubMed     Text format     Abstract available


  91. PACKER M
    Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparators.
    Int J Cardiol. 2018 Mar 11. pii: S0167-5273(18)31152.
    PubMed     Text format     Abstract available


  92. NAKANO H, Nagai T, Sundaram V, Nakai M, et al
    Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure.
    Int J Cardiol. 2018 Mar 11. pii: S0167-5273(17)36425.
    PubMed     Text format     Abstract available


  93. GOMES NETO M, Duraes AR, Conceicao LSR, Saquetto MB, et al
    High intensity interval training versus moderate intensity continuous training on exercise capacity and quality of life in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Mar 5. pii: S0167-5273(17)37879.
    PubMed     Text format     Abstract available


  94. SAFIRI S, Khazaei S, Ayubi E
    Vascular expansion during worsening of heart failure: Effects on clinical features and its determinants: Methodological issues to avoid misinterpretation.
    Int J Cardiol. 2018;254:260.
    PubMed     Text format    


  95. ROSSINI R, Iorio A
    The gap in heart failure: Understanding pulse pressure across heart failure phenotypes in the real world.
    Int J Cardiol. 2018;254:254-255.
    PubMed     Text format    


  96. PASSINO C, Aimo A, Mirizzi G, Emdin M, et al
    Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms?
    Int J Cardiol. 2018;254:248-249.
    PubMed     Text format    


  97. NOCHIOKA K
    Urinary sodium excretion in acute heart failure: Interaction between heart and kidney.
    Int J Cardiol. 2018;254:244-245.
    PubMed     Text format    


  98. EMDIN M, Aimo A, Gabutti A, Giannoni A, et al
    Underprescription of disease-modifying drugs in chronic heart failure: More is better?
    Int J Cardiol. 2018;254:242-243.
    PubMed     Text format    


  99. AIMO A, Barison A, Mammini C, Emdin M, et al
    The Barthel Index in elderly acute heart failure patients. Frailty matters.
    Int J Cardiol. 2018;254:240-241.
    PubMed     Text format    


  100. MONTERO D, Diaz-Canestro C
    Determinants of exercise intolerance in heart failure with preserved ejection fraction: A systematic review and meta-analysis.
    Int J Cardiol. 2018;254:224-229.
    PubMed     Text format     Abstract available


  101. IBRAHIM NE, Song Y, Cannon CP, Doros G, et al
    Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Regi
    Int J Cardiol. 2018;254:222-223.
    PubMed     Text format    


  102. VODOVAR N, Mebazaa A, Januzzi JL Jr., Murtagh G, et al
    Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials.
    Int J Cardiol. 2018;254:215-221.
    PubMed     Text format     Abstract available


  103. TENG TK, Tay WT, Dahlstrom U, Benson L, et al
    Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.
    Int J Cardiol. 2018;254:203-209.
    PubMed     Text format     Abstract available


  104. HONDA S, Nagai T, Nishimura K, Nakai M, et al
    Long-term prognostic significance of urinary sodium concentration in patients with acute heart failure.
    Int J Cardiol. 2018;254:189-194.
    PubMed     Text format     Abstract available


  105. CHIVITE D, Formiga F, Corbella X, Conde-Martel A, et al
    Basal functional status predicts one-year mortality after a heart failure hospitalization in elderly patients - The RICA prospective study.
    Int J Cardiol. 2018;254:182-188.
    PubMed     Text format     Abstract available


  106. IBRAHIM NE, Song Y, Cannon CP, Doros G, et al
    Retraction notice to Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clin
    Int J Cardiol. 2018;254:R1.
    PubMed     Text format    


    February 2018
  107. MONEGHETTI KJ, Hock J, Kaminsky L, Arena R, et al
    Applying current normative data to prognosis in heart failure: The Fitness Registry and the Importance of Exercise National Database (FRIEND).
    Int J Cardiol. 2018 Feb 27. pii: S0167-5273(17)35382.
    PubMed     Text format     Abstract available


  108. CASTELVECCHIO S, Baryshnikova E, Pina IL, Ambrogi F, et al
    Longitudinal profile of NT-proBNP levels in ischemic heart failure patients undergoing surgical ventricular reconstruction: The Biomarker Plus study.
    Int J Cardiol. 2018 Feb 26. pii: S0167-5273(17)36355.
    PubMed     Text format     Abstract available


  109. TER MAATEN JM, Voors AA, Damman K, van der Meer P, et al
    Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.
    Int J Cardiol. 2018;253:84-90.
    PubMed     Text format     Abstract available


  110. TIMMERMANS I, Denollet J, Pedersen SS, Meine M, et al
    Patient-reported causes of heart failure in a large European sample.
    Int J Cardiol. 2018 Feb 6. pii: S0167-5273(17)34169.
    PubMed     Text format     Abstract available


  111. STEINMETZ M, Broder M, Hosch O, Lamata P, et al
    Atrio-ventricular deformation and heart failure in Ebstein's Anomaly - A cardiovascular magnetic resonance study.
    Int J Cardiol. 2018 Feb 2. pii: S0167-5273(17)30718.
    PubMed     Text format     Abstract available


  112. CHUGH SS
    Heart failure and atrial fibrillation: Can we break this nexus?
    Int J Cardiol. 2018;252:142-143.
    PubMed     Text format    


  113. ZIFF OJ, Carter PR, McGowan J, Uppal H, et al
    The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry.
    Int J Cardiol. 2018;252:117-121.
    PubMed     Text format     Abstract available


  114. GRODIN JL, Mullens W, Dupont M, Taylor DO, et al
    Hemodynamic factors associated with serum chloride in ambulatory patients with advanced heart failure.
    Int J Cardiol. 2018;252:112-116.
    PubMed     Text format     Abstract available


    January 2018
  115. MOLINER P, Lupon J, Barallat J, de Antonio M, et al
    Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.
    Int J Cardiol. 2018 Jan 31. pii: S0167-5273(17)35080.
    PubMed     Text format     Abstract available


  116. SMEETS M, Henrard S, Aertgeerts B, Cools F, et al
    Methods to identify heart failure patients in general practice and their impact on patient characteristics: A systematic review.
    Int J Cardiol. 2018 Jan 30. pii: S0167-5273(17)32085.
    PubMed     Text format     Abstract available


  117. FONSECA C, Maggioni AP, Marques F, Araujo I, et al
    Erratum to "A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure" [Int. J. Cardiol. 250 (2018) 215-222].
    Int J Cardiol. 2018 Jan 11. pii: S0167-5273(17)37614.
    PubMed     Text format    


  118. STOLFO D, De Luca A, Morea G, Merlo M, et al
    Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection.
    Int J Cardiol. 2018 Jan 6. pii: S0167-5273(17)36678.
    PubMed     Text format     Abstract available


  119. TSUJIMOTO T, Kajio H
    Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease.
    Int J Cardiol. 2018 Jan 4. pii: S0167-5273(17)34189.
    PubMed     Text format     Abstract available


  120. GUISADO-ESPARTERO ME, Salamanca-Bautista P, Aramburu-Bodas O, Conde-Martel A, et al
    Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: Findings from the RICA Registry.
    Int J Cardiol. 2018 Jan 2. pii: S0167-5273(17)30729.
    PubMed     Text format     Abstract available


  121. EMDIN M, Aimo A, Passino C, Giannoni A, et al
    Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart.
    Int J Cardiol. 2018;250:231-232.
    PubMed     Text format    


  122. WAKABAYASHI K, Ikeda N, Kajimoto K, Minami Y, et al
    Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure.
    Int J Cardiol. 2018;250:164-170.
    PubMed     Text format     Abstract available


    December 2017
  123. ZIVLAS C, Foley PWX
    Ivabradine - well tolerated in elderly patients with systolic heart failure.
    Int J Cardiol. 2017;249:330-331.
    PubMed     Text format    


  124. MASCI PG
    Negative risk markers for improving prediction of heart failure: Risk stratification implementation or simply the other side of existing risk scores?
    Int J Cardiol. 2017;249:328-329.
    PubMed     Text format    


  125. ZACHARIAH D, Stevens D, Sidorowicz G, Spooner C, et al
    Quality of life improvement in older patients with heart failure initiated on ivabradine: Results from the UK multi-centre LIVE:LIFE prospective cohort study.
    Int J Cardiol. 2017;249:313-318.
    PubMed     Text format     Abstract available


  126. BROUGHTON ST, O'Neal WT, Al-Mallah M, Bluemke DA, et al
    Normal findings on noninvasive cardiac assessment and the prediction of heart failure: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Int J Cardiol. 2017;249:308-312.
    PubMed     Text format     Abstract available


  127. LUO H, Xu Y, Yue F, Zhang C, et al
    Quality of inclusion criteria in the registered clinical trials of heart failure with preserved ejection fraction: Is it time for a change?
    Int J Cardiol. 2017 Dec 15. pii: S0167-5273(17)30019.
    PubMed     Text format     Abstract available


  128. OLIVA F, Sormani P, Contri R, Campana C, et al
    Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure.
    Int J Cardiol. 2017 Dec 14. pii: S0167-5273(17)30300.
    PubMed     Text format     Abstract available


  129. DEL TORTO A, Corrieri N, Vignati C, Gentile P, et al
    Corrigendum to "Contribution of central and peripheral factors at peak exercise in heart failure patients with progressive severity of exercise limitation." [Int. J. Cardiol. 248 (2017) 252-256].
    Int J Cardiol. 2017 Dec 14. pii: S0167-5273(17)37309.
    PubMed     Text format    


  130. EMDIN M, Aimo A, Passino C, Vergaro G, et al
    Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry.
    Int J Cardiol. 2017;248:278-279.
    PubMed     Text format    


  131. KLEBER FX
    Reduced arteriovenous oxygen difference on exercise in heart failure.
    Int J Cardiol. 2017;248:276-277.
    PubMed     Text format    


  132. BUENO H, Martin-Asenjo R
    Acute heart failure after STEMI. Still a problem, still an opportunity for improving care quality.
    Int J Cardiol. 2017;248:274-275.
    PubMed     Text format    


  133. DEL TORTO A, Corrieri N, Vignati C, Gentile P, et al
    Contribution of central and peripheral factors at peak exercise in heart failure patients with progressive severity of exercise limitation.
    Int J Cardiol. 2017;248:252-256.
    PubMed     Text format     Abstract available


    November 2017
  134. WANNAMETHEE SG, Papacosta O, Lennon L, Whincup PH, et al
    Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study.
    Int J Cardiol. 2017 Nov 28. pii: S0167-5273(17)35928.
    PubMed     Text format     Abstract available


  135. KUPERSTEIN R, Klempfner R, Ofek E, Maor E, et al
    De novo mitral regurgitation as a cause of heart failure exacerbation in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2017 Nov 21. pii: S0167-5273(17)35208.
    PubMed     Text format    


  136. MIZZACI CC, Porfirio GJM, Vilela AT, Guillhen JCS, et al
    Retraction notice to "Ivabradine as adjuvant treatment for chronic heart failure" [Int. J. Cardiol. 227 (2017) 43-50].
    Int J Cardiol. 2017;247:55.
    PubMed     Text format    


  137. ISHIDA J, Springer J
    Reply to letter to the editor "suramin against myostatin signaling may be considered to intervene in female patients with advanced heart failure".
    Int J Cardiol. 2017;247:48.
    PubMed     Text format    


  138. WU Y, Sun X
    Suramin against myostatin signaling may be considered to intervene in female patients with advanced heart failure.
    Int J Cardiol. 2017;247:44.
    PubMed     Text format    


  139. YUCEL O, Yucel H, Zorlu A
    D-dimer is a predictor of cardiovascular death, and new-onset atrial fibrillation in patients with systolic heart failure.
    Int J Cardiol. 2017;247:39.
    PubMed     Text format    


  140. LUO H, Xu Y, Zhang X
    Kaplan-Meier curve of retrospective study: Do not misuse it!
    Int J Cardiol. 2017;247:28.
    PubMed     Text format    


  141. GIULIANO C, Neil C, Levinger I
    Letter to the editor: "The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals".
    Int J Cardiol. 2017;246:56.
    PubMed     Text format    


    October 2017
  142. VAN DE BRUAENE A, Hickey EJ, Kovacs AH, Crean AM, et al
    Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure.
    Int J Cardiol. 2017 Oct 31. pii: S0167-5273(17)32248.
    PubMed     Text format     Abstract available


  143. SUTHAHAR N, Meijers WC, Brouwers FP, Heerspink HJL, et al
    Heart failure and inflammation-related biomarkers as predictors of new-onset diabetes in the general population.
    Int J Cardiol. 2017 Oct 16. pii: S0167-5273(17)34233.
    PubMed     Text format     Abstract available


  144. CAMPODONICO J, Cosentino N, Agostoni P
    The "hands-on" patient-centered method: An old approach for a new perspective in acute heart failure.
    Int J Cardiol. 2017;245:213-214.
    PubMed     Text format    


  145. TAVAZZI G, Neskovic AN, Hussain A, Volpicelli G, et al
    A plea for an early ultrasound-clinical integrated approach in patients with acute heart failure. A proactive comment on the ESC Guidelines on Heart Failure 2016.
    Int J Cardiol. 2017;245:207-210.
    PubMed     Text format     Abstract available


  146. VAN ITERSON EH, Olson TP
    Use of 'ideal' alveolar air equations and corrected end-tidal PCO2 to estimate arterial PCO2 and physiological dead space during exercise in patients with heart failure.
    Int J Cardiol. 2017 Oct 7. pii: S0167-5273(17)32958.
    PubMed     Text format     Abstract available


  147. FONSECA C, Maggioni AP, Marques F, Araujo I, et al
    A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure.
    Int J Cardiol. 2017 Oct 6. pii: S0167-5273(16)34125.
    PubMed     Text format     Abstract available


  148. MARTENS P, Verbrugge FH, Boonen L, Nijst P, et al
    Value of routine investigations to predict loop diuretic down-titration success in stable heart failure.
    Int J Cardiol. 2017 Oct 6. pii: S0167-5273(17)32210.
    PubMed     Text format     Abstract available


  149. LUND A, Giil LM, Slettom G, Nygaard O, et al
    Antibodies to receptors are associated with biomarkers of inflammation and myocardial damage in heart failure.
    Int J Cardiol. 2017 Oct 5. pii: S0167-5273(17)34085.
    PubMed     Text format     Abstract available


    September 2017
  150. SHAH M, Patnaik S, Patel B, Arora S, et al
    The day of the week and acute heart failure admissions: Relationship with acute myocardial infarction, 30-day readmission rate and in-hospital mortality.
    Int J Cardiol. 2017 Sep 29. pii: S0167-5273(16)34002.
    PubMed     Text format     Abstract available


  151. AGEWALL S, Tjessem LH, Rossignol P, Zannad F, et al
    Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative.
    Int J Cardiol. 2017 Sep 24. pii: S0167-5273(17)30523.
    PubMed     Text format     Abstract available


  152. XUAN W, Huang W, Wang R, Chen C, et al
    Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction.
    Int J Cardiol. 2017;243:367-373.
    PubMed     Text format     Abstract available


  153. YAMADA S, Lo LW, Chen SA
    Reply to letter to the editor: "A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation".
    Int J Cardiol. 2017;243:282.
    PubMed     Text format    


  154. YI X, Feng G, Jiang X
    A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation.
    Int J Cardiol. 2017;243:281.
    PubMed     Text format    


  155. WAKILI R, Dobrev D
    Role of triggers and substrate in heart failure based atrial fibrillation: Is pulmonary vein isolation still the cornerstone of atrial fibrillation therapy?
    Int J Cardiol. 2017;243:276-278.
    PubMed     Text format    


  156. VAINSHELBOIM B, Amin A, Christle JW, Hebbal S, et al
    A method for determining exercise oscillatory ventilation in heart failure: Prognostic value and practical implications.
    Int J Cardiol. 2017 Sep 14. pii: S0167-5273(17)32062.
    PubMed     Text format     Abstract available


  157. WANG S, Su Z, Wu Z, Yu Q, et al
    Assessment of current use of guideline-based medical therapy in elderly patients with heart failure.
    Int J Cardiol. 2017;242:34.
    PubMed     Text format    


    August 2017
  158. AGRICOLA E, Marini C
    Corrigendum to "Lung ultrasound predicts decompensation in heart failure outpatients: Another piece to the puzzle but still an incomplete picture" [Int. J. Cardiol. 240 (2017) 324-325].
    Int J Cardiol. 2017 Aug 28. pii: S0167-5273(17)34425.
    PubMed     Text format    


  159. VERSCHURE DO, de Groot JR, Mirzaei S, Gheysens O, et al
    Cardiac 123I-mIBG scintigraphy is associated with freedom of appropriate ICD therapy in stable chronic heart failure patients.
    Int J Cardiol. 2017 Aug 25. pii: S0167-5273(17)33211.
    PubMed     Text format     Abstract available


  160. CHIN A, Ntsekhe M, Viljoen C, Rossouw J, et al
    Rationale and design of a prospective study to assess the effect of left cardiac sympathetic denervation in chronic heart failure.
    Int J Cardiol. 2017 Aug 8. pii: S0167-5273(17)34427.
    PubMed     Text format     Abstract available


  161. PARK JJ, Cho YJ, Oh IY, Park HA, et al
    Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.
    Int J Cardiol. 2017 Aug 5. pii: S0167-5273(17)33597.
    PubMed     Text format     Abstract available


  162. FERNANDEZ-GASSO L, Hernando-Arizaleta L, Palomar-Rodriguez JA, Abellan-Perez MV, et al
    Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data.
    Int J Cardiol. 2017 Aug 4. pii: S0167-5273(17)33042.
    PubMed     Text format     Abstract available


  163. RIVA MA, Cesana F, Achilli F, Scordo F, et al
    The "thirsty dropsy": Early descriptions in medical and non-medical authors of thirst as symptom of chronic heart failure.
    Int J Cardiol. 2017 Aug 3. pii: S0167-5273(17)32582.
    PubMed     Text format     Abstract available


  164. AGRICOLA E, Marini C
    Lung ultrasound predicts decompensation in heart failure outpatients: Another piece to the puzzle but still an incomplete picture.
    Int J Cardiol. 2017;240:324-325.
    PubMed     Text format    


  165. MIGLIORANZA MH, Picano E, Badano LP, Sant'Anna R, et al
    Pulmonary congestion evaluated by lung ultrasound predicts decompensation in heart failure outpatients.
    Int J Cardiol. 2017;240:271-278.
    PubMed     Text format     Abstract available


  166. RODRIGUEZ-MANERO M, Cordero A, Kreidieh O, Garcia-Acuna JM, et al
    Proposal of a novel clinical score to predict heart failure incidence in long-term survivors of acute coronary syndromes.
    Int J Cardiol. 2017 Aug 1. pii: S0167-5273(17)31821.
    PubMed     Text format     Abstract available


    July 2017
  167. MOUTON S, Ridon H, Fertin M, Pentiah AD, et al
    2D-speckle tracking right ventricular strain to assess right ventricular systolic function in systolic heart failure. Analysis of the right ventricular free and posterolateral walls.
    Int J Cardiol. 2017 Jul 25. pii: S0167-5273(17)32356.
    PubMed     Text format     Abstract available


  168. KANG SH, Kim J, Park JJ, Oh IY, et al
    Risk of stroke in congestive heart failure with and without atrial fibrillation.
    Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
    PubMed     Text format     Abstract available


  169. PEREGO GB, Oldani M, Pellegrini D, Brasca FMA, et al
    Correlation between pulmonary artery pressure and thoracic impedance: Insights from daily monitoring through an implanted device in chronic heart failure.
    Int J Cardiol. 2017 Jul 17. pii: S0167-5273(17)32090.
    PubMed     Text format     Abstract available


  170. WANG JZ, Du WT, Liu GJ
    Limit the uptake of milk by young people: A method to prevent the occurrence of heart failure.
    Int J Cardiol. 2017;239:18.
    PubMed     Text format    


  171. CORBINEAU S, Breton M, Mialet-Perez J, Costemale-Lacoste JF, et al
    Major depression and heart failure: Interest of monoamine oxidase inhibitors.
    Int J Cardiol. 2017 Jul 8. pii: S0167-5273(17)34029.
    PubMed     Text format     Abstract available


  172. GRUSON D, Ferracin B, Ahn SA, Rousseau MF, et al
    Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction.
    Int J Cardiol. 2017 Jul 5. pii: S0167-5273(17)30763.
    PubMed     Text format    


  173. AZADANI PN, King JB, Kheirkhahan M, Chang L, et al
    Left atrial fibrosis is associated with new-onset heart failure in patients with atrial fibrillation.
    Int J Cardiol. 2017 Jul 5. pii: S0167-5273(17)32655.
    PubMed     Text format    


    June 2017
  174. DRISCOLL A, Barnes EH, Blankenberg S, Colquhoun DM, et al
    Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction model.
    Int J Cardiol. 2017 Jun 30. pii: S0167-5273(16)34461.
    PubMed     Text format     Abstract available


  175. KASAMA S, Toyama T, Kurabayashi M
    Comparative effects of long and short-acting loop diuretics on mortality in patients with chronic heart failure.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)32016.
    PubMed     Text format     Abstract available


  176. DE FERRARI GM, Stolen C, Tuinenburg AE, Wright DJ, et al
    Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial.
    Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)31295.
    PubMed     Text format     Abstract available


  177. PENICKA M, Kotrc M, Ondrus T, Mo Y, et al
    Minimally invasive mitral valve annuloplasty confers a long-term survival benefit compared with state-of-the-art treatment in heart failure with functional mitral regurgitation.
    Int J Cardiol. 2017 Jun 8. pii: S0167-5273(17)31033.
    PubMed     Text format     Abstract available


  178. EMDIN M, Aimo A, Vergaro G, Passino C, et al
    Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators.
    Int J Cardiol. 2017;236:348-349.
    PubMed     Text format    


  179. FORMIGA F, Masip J, Chivite D, Corbella X, et al
    Applicability of the heart failure Readmission Risk score: A first European study.
    Int J Cardiol. 2017;236:304-309.
    PubMed     Text format     Abstract available


  180. LYNGGAARD V, Nielsen CV, Zwisler AD, Taylor RS, et al
    The patient education - Learning and Coping Strategies - improves adherence in cardiac rehabilitation (LC-REHAB): A randomised controlled trial.
    Int J Cardiol. 2017;236:65-70.
    PubMed     Text format     Abstract available


  181. D'ONOFRIO A, Palmisano P, Rapacciuolo A, Ammendola E, et al
    Effectiveness of a management program for outpatient clinic or remote titration of beta-blockers in CRT patients: The RESTORE study.
    Int J Cardiol. 2017;236:290-295.
    PubMed     Text format     Abstract available


    May 2017
  182. DIXON DL, De Pasquale CG, Lawrence MD, Cavallaro E, et al
    Lung fluid clearance in chronic heart failure patients.
    Int J Cardiol. 2017 May 26. pii: S0167-5273(16)34040.
    PubMed     Text format     Abstract available


  183. DESTA L, Jernberg T, Spaak J, Hofman-Bang C, et al
    Risk and predictors of readmission for heart failure following a myocardial infarction between 2004 and 2013: A Swedish nationwide observational study.
    Int J Cardiol. 2017 May 24. pii: S0167-5273(16)34867.
    PubMed     Text format     Abstract available


  184. POLZL G, Altenberger J, Baholli L, Beltran P, et al
    Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
    Int J Cardiol. 2017 May 23. pii: S0167-5273(17)31017.
    PubMed     Text format     Abstract available


  185. BALDI I, Azzolina D, Berchialla P, Gregori D, et al
    Comorbidity-adjusted relative survival in newly hospitalized heart failure patients: A population-based study.
    Int J Cardiol. 2017 May 22. pii: S0167-5273(17)31500.
    PubMed     Text format     Abstract available


  186. AGRA BERMEJO R, Varela Roman A, Gomez Otero I, Gonzalez Ferreiro R, et al
    Letter to editor in response to Formiga et al. "Utility of the Controlling Nutritional Status (CONUT) score in patients admitted due to acute heart failure".
    Int J Cardiol. 2017;235:204.
    PubMed     Text format    


  187. FORMIGA F, Chivite D, Corbella X
    Utility of the Controlling Nutritional Status (CONUT) score in patients admitted due to acute heart failure.
    Int J Cardiol. 2017;235:203.
    PubMed     Text format    


  188. HIDALGO FJ, Anguita M
    Ivabradine in acute decompensated systolic heart failure.
    Int J Cardiol. 2017;235:198.
    PubMed     Text format    


  189. SARGENTO L
    Ivabradine in acute decompensated systolic heart failure.
    Int J Cardiol. 2017;235:197.
    PubMed     Text format    


  190. EYUBOGLU M
    Prognostic factors in the heart failure with reduced ejection fraction.
    Int J Cardiol. 2017;235:187.
    PubMed     Text format    


  191. STEWART COATS AJ, Shewan LG
    A comparison of research into cachexia, wasting and related skeletal muscle syndromes in three chronic disease areas.
    Int J Cardiol. 2017;235:33-36.
    PubMed     Text format     Abstract available


  192. SECO M, Zhao DF, Byrom MJ, Wilson MK, et al
    Long-term prognosis and cost-effectiveness of left ventricular assist device as bridge to transplantation: A systematic review.
    Int J Cardiol. 2017;235:22-32.
    PubMed     Text format     Abstract available


  193. NIJST P, Verbrugge FH, Martens P, Dupont M, et al
    Renal response to intravascular volume expansion in euvolemic heart failure patients with reduced ejection fraction: Mechanistic insights and clinical implications.
    Int J Cardiol. 2017 May 14. pii: S0167-5273(17)31183.
    PubMed     Text format     Abstract available


  194. CASADO J, Sanchez M, Garces V, Manzano L, et al
    Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
    Int J Cardiol. 2017 May 12. pii: S0167-5273(16)32858.
    PubMed     Text format     Abstract available


  195. ROBERTSON J, Schioler L, Toren K, Soderberg M, et al
    Mental disorders and stress resilience in adolescence and long-term risk of early heart failure among Swedish men.
    Int J Cardiol. 2017 May 10. pii: S0167-5273(16)34479.
    PubMed     Text format     Abstract available


  196. KINGERY JR, Yango M, Wajanga B, Kalokola F, et al
    Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study.
    Int J Cardiol. 2017 May 9. pii: S0167-5273(16)33889.
    PubMed     Text format     Abstract available


  197. TSIMPLOULIS A, Sheriff HM, Lam PH, Dooley DJ, et al
    Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16].
    Int J Cardiol. 2017 May 6. pii: S0167-5273(17)32436.
    PubMed     Text format    


  198. TURCATO G, Zorzi E, Prati D, Ricci G, et al
    Early in-hospital variation of red blood cell distribution width predicts mortality in patients with acute heart failure.
    Int J Cardiol. 2017 May 6. pii: S0167-5273(17)31187.
    PubMed     Text format     Abstract available


  199. AKITA K, Kohno T, Kohsaka S, Mizuno A, et al
    Author's reply: Assessment of current use of guideline-based medical therapy in elderly patients with heart failure.
    Int J Cardiol. 2017 May 6. pii: S0167-5273(17)32618.
    PubMed     Text format    


  200. MOLINER P, Jankowska EA, van Veldhuisen DJ, Farre N, et al
    Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure.
    Int J Cardiol. 2017 May 3. pii: S0167-5273(16)33235.
    PubMed     Text format     Abstract available


  201. MORPURGO M, Pasqualini M, Brunazzi MC, Vianello G, et al
    A multicenter feasibility study on ultrafiltration via a single peripheral venous access in acute heart failure with overt fluid overload.
    Int J Cardiol. 2017 May 2. pii: S0167-5273(16)33118.
    PubMed     Text format     Abstract available


  202. IACOVIELLO M, Monitillo F, Citarelli G, Leone M, et al
    Right ventriculo-arterial coupling assessed by two-dimensional strain: A new parameter of right ventricular function independently associated with prognosis in chronic heart failure patients.
    Int J Cardiol. 2017 May 1. pii: S0167-5273(16)33807.
    PubMed     Text format     Abstract available


    April 2017
  203. MIZUNO A, Iguchi H, Sawada Y, Hurley M, et al
    The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: High value care vs. low value care campaign in Japan.
    Int J Cardiol. 2017 Apr 26. pii: S0167-5273(17)30779.
    PubMed     Text format     Abstract available


  204. KIMURA Y, Noda T, Matsuyama TA, Otsuka Y, et al
    Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: What are the risk factors?
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(17)30192.
    PubMed     Text format     Abstract available


  205. SANTAS E, de la Espriella-Juan R, Mollar A, Valero E, et al
    Echocardiographic pulmonary artery pressure estimation and heart failure rehospitalization burden in patients with acute heart failure.
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(17)30752.
    PubMed     Text format     Abstract available


  206. AKSU U
    Outpatient follow-up during the first year after heart transplantation.
    Int J Cardiol. 2017;233:93.
    PubMed     Text format    


  207. KWOK CS, Bagur R, Rashid M, Lavi R, et al
    Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34897.
    PubMed     Text format     Abstract available


  208. ZUGCK C, Stork S, Stockl G
    Long-term treatment with ivabradine over 12months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations.
    Int J Cardiol. 2017 Apr 10. pii: S0167-5273(17)30114.
    PubMed     Text format     Abstract available


  209. ISHIDA J, Konishi M, Saitoh M, Anker M, et al
    Myostatin signaling is up-regulated in female patients with advanced heart failure.
    Int J Cardiol. 2017 Apr 4. pii: S0167-5273(17)32064.
    PubMed     Text format     Abstract available


  210. AKODAD M, Fauconnier J, Sicard P, Huet F, et al
    Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model.
    Int J Cardiol. 2017 Apr 1. pii: S0167-5273(16)34092.
    PubMed     Text format     Abstract available


  211. SAITOH M, Ishida J, Doehner W, von Haehling S, et al
    Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
    Int J Cardiol. 2017 Apr 1. pii: S0167-5273(17)32066.
    PubMed     Text format     Abstract available


  212. KOSTIC T, Momcilovic S, Perisic ZD, Apostolovic SR, et al
    Manifestations of Lyme carditis.
    Int J Cardiol. 2017;232:24-32.
    PubMed     Text format     Abstract available


  213. WALLENBORN J, Marx A, Stork S, Guder G, et al
    Prognostic significance of serial high-sensitivity troponin I measurements following acute cardiac decompensation-correlation with longer-term clinical outcomes and reverse remodelling.
    Int J Cardiol. 2017;232:199-207.
    PubMed     Text format     Abstract available


  214. MURPHY TM, Waterhouse DF, James S, Casey C, et al
    A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program.
    Int J Cardiol. 2017;232:330-335.
    PubMed     Text format     Abstract available


    March 2017
  215. MENDES LV, Gonsalez SR, Oliveira-Pinto LM, Pereira-Acacio A, et al
    Long-term effect of a chronic low-protein multideficient diet on the heart: Hypertension and heart failure in chronically malnourished young adult rats.
    Int J Cardiol. 2017 Mar 27. pii: S0167-5273(17)31864.
    PubMed     Text format     Abstract available


  216. HERNAN GOMEZ LLAMBI H, Cao G, Donato M, Suarez D, et al
    Left ventricular hypertrophy does not prevent heart failure in experimental hypertension.
    Int J Cardiol. 2017 Mar 27. pii: S0167-5273(17)31863.
    PubMed     Text format     Abstract available


  217. TSENG WC, Liu JS, Hung SC, Kuo KL, et al
    Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 18. pii: S0167-5273(17)31725.
    PubMed     Text format     Abstract available


  218. RINKUNIENE D, Krivickiene A, Laukaitiene J, Jurkevicius R, et al
    Pharmacological treatment changes of chronic heart failure during cardiac resynchronization therapy: A 1-year follow-up study.
    Int J Cardiol. 2017 Mar 14. pii: S0167-5273(17)31610.
    PubMed     Text format     Abstract available


  219. LOURENCO P, Silva S, Cunha F, Pereira J, et al
    Dipeptidyl peptidase-IV in chronic heart failure with reduced ejection fraction.
    Int J Cardiol. 2017 Mar 11. pii: S0167-5273(16)33739.
    PubMed     Text format     Abstract available


  220. PASCUAL-FIGAL DA, Ferrero-Gregori A, Gomez-Otero I, Vazquez R, et al
    Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.
    Int J Cardiol. 2017 Mar 9. pii: S0167-5273(17)30596.
    PubMed     Text format     Abstract available


  221. FROHLICH H, Raman N, Tager T, Schellberg D, et al
    Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure.
    Int J Cardiol. 2017 Mar 9. pii: S0167-5273(17)31523.
    PubMed     Text format     Abstract available


  222. BONSU KO, Owusu IK, Buabeng KO, Reidpath DD, et al
    Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients.
    Int J Cardiol. 2017 Mar 6. pii: S0167-5273(17)31424.
    PubMed     Text format     Abstract available


  223. AMIR O, Ben-Gal T, Weinstein JM, Schliamser J, et al
    Evaluation of remote dielectric sensing (ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations.
    Int J Cardiol. 2017 Mar 3. pii: S0167-5273(16)32225.
    PubMed     Text format     Abstract available


  224. MONAHAN M, Barton P, Taylor CJ, Roalfe AK, et al
    MICE or NICE? An economic evaluation of clinical decision rules in the diagnosis of heart failure in primary care.
    Int J Cardiol. 2017 Mar 2. pii: S0167-5273(16)33702.
    PubMed     Text format     Abstract available


  225. TSIMPLOULIS A, Sheriff HM, Lam PH, Dooley DJ, et al
    Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
    Int J Cardiol. 2017 Mar 1. pii: S0167-5273(17)31290.
    PubMed     Text format     Abstract available


  226. SHERIFF HM, Tsimploulis A, Valentova M, Anker MS, et al
    Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study.
    Int J Cardiol. 2017 Mar 1. pii: S0167-5273(17)31293.
    PubMed     Text format     Abstract available


  227. VIGNATI C, Apostolo A, Cattadori G, Farina S, et al
    Lvad pump speed increase is associated with increased peak exercise cardiac output and vo2, postponed anaerobic threshold and improved ventilatory efficiency.
    Int J Cardiol. 2017;230:28-32.
    PubMed     Text format     Abstract available


    February 2017
  228. USZKO-LENCER NH, Mesquita R, Janssen E, Werter C, et al
    Reliability, construct validity and determinants of 6-minute walk test performance in patients with chronic heart failure.
    Int J Cardiol. 2017 Feb 28. pii: S0167-5273(16)32866.
    PubMed     Text format     Abstract available


  229. ABI KHALIL C, Sulaiman K, Singh R, Jayyousi A, et al
    BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: Findings from the Gulf aCute heArt failuRE (Gulf-CARE) registry.
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(16)34386.
    PubMed     Text format     Abstract available


  230. AKITA K, Kohno T, Kohsaka S, Shiraishi Y, et al
    Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31098.
    PubMed     Text format     Abstract available


  231. ALHABEEB W, Elasfar A, AlBackr H, AlShaer F, et al
    Clinical characteristics, management and outcomes of patients with chronic heart failure: Results from the heart function assessment registry trial in Saudi Arabia (HEARTS-chronic).
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31118.
    PubMed     Text format     Abstract available


  232. YAMADA S, Lo LW, Chou YH, Lin WL, et al
    Renal denervation regulates the atrial arrhythmogenic substrates through reverse structural remodeling in heart failure rabbit model.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31114.
    PubMed     Text format     Abstract available


  233. VAN BOVEN N, Akkerhuis KM, Anroedh SS, Rizopoulos D, et al
    Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31107.
    PubMed     Text format     Abstract available


  234. SZMIT S, Jurczak W, Zaucha JM, Dlugosz-Danecka M, et al
    Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31101.
    PubMed     Text format     Abstract available


  235. ANSELMINO M, Matta M, Bunch TJ, Fiala M, et al
    Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(16)33338.
    PubMed     Text format     Abstract available


  236. AMIN A, von Haehling S
    Updates in heart failure: Highlights from the Iranian Joint Cardiovascular Congress Tehran, Iran, 1-4 March 2016.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31117.
    PubMed     Text format    


  237. MAFFESSANTI F, Wanten J, Potse M, Regoli F, et al
    The relation between local repolarization and T-wave morphology in heart failure patients.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(16)34312.
    PubMed     Text format     Abstract available


  238. YOSHIDA M, Ando SI, Kodama K, Ebihara K, et al
    Adaptive servo-ventilation therapy reduces hospitalization rate in patients with severe heart failure.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31105.
    PubMed     Text format     Abstract available


  239. FRIGERIO M, Mazzali C, Paganoni AM, Ieva F, et al
    Trends in heart failure hospitalizations, patient characteristics, in-hospital and 1-year mortality: A population study, from 2000 to 2012 in Lombardy.
    Int J Cardiol. 2017 Feb 21. pii: S0167-5273(16)34743.
    PubMed     Text format     Abstract available


  240. KARLSTROM P, Johansson P, Dahlstrom U, Boman K, et al
    The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study.
    Int J Cardiol. 2017 Feb 17. pii: S0167-5273(16)33177.
    PubMed     Text format     Abstract available


  241. RIZZI MA, Alquezar Arbe A, Martin Marcuello J, Hernandez Ontiveros H, et al
    Delirium in heart failure.
    Int J Cardiol. 2017;229:132.
    PubMed     Text format    


  242. COWIE MR, Lopatin YM, Saldarriaga C, Fonseca C, et al
    The Optimize Heart Failure Care Program: Initial lessons from global implementation.
    Int J Cardiol. 2017 Feb 12. pii: S0167-5273(17)30746.
    PubMed     Text format     Abstract available


  243. MONTONE RA, Niccoli G, Minelli S, Fracassi F, et al
    Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction.
    Int J Cardiol. 2017 Feb 12. pii: S0167-5273(16)34261.
    PubMed     Text format     Abstract available


  244. DENFELD QE, Winters-Stone K, Mudd JO, Gelow JM, et al
    The prevalence of frailty in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Feb 10. pii: S0167-5273(16)32977.
    PubMed     Text format     Abstract available


  245. RODRIGUEZ-PASCUAL C, Paredes-Galan E, Ferrero-Martinez AI, Gonzalez-Guerrero JL, et al
    The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals.
    Int J Cardiol. 2017 Feb 8. pii: S0167-5273(16)34474.
    PubMed     Text format     Abstract available


  246. OLIVIER A, Girerd N, Michel JB, Ketelslegers JM, et al
    Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Pos
    Int J Cardiol. 2017 Feb 8. pii: S0167-5273(16)32115.
    PubMed     Text format     Abstract available


  247. AGRINIER N, Thilly N, Briancon S, Juilliere Y, et al
    Prognostic factors associated with 15-year mortality in patients with hospitalized systolic HF: Results of the observational community-based EPICAL cohort study.
    Int J Cardiol. 2017;228:940-947.
    PubMed     Text format     Abstract available


  248. XU XQ, Lv ZC, Liu QQ, Zhao QH, et al
    Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.
    Int J Cardiol. 2017;228:895-899.
    PubMed     Text format     Abstract available


  249. FAXEN UL, Hage C, Andreasson A, Donal E, et al
    HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin.
    Int J Cardiol. 2017;228:709-716.
    PubMed     Text format     Abstract available


  250. ALOTAIBI S, Erbel R, Neumann T
    Left ventricular assist devices and gastrointestinal evaluation: Results of a consecutive case series.
    Int J Cardiol. 2017;228:149-150.
    PubMed     Text format     Abstract available


  251. KOBE J, Andresen D, Maier S, Stellbrink C, et al
    Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age - Insights from the German Device Registry.
    Int J Cardiol. 2017;228:784-789.
    PubMed     Text format     Abstract available


    January 2017
  252. KHALID U, Wruck LM, Quibrera PM, Bozkurt B, et al
    BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Int J Cardiol. 2017 Jan 31. pii: S0167-5273(17)30599.
    PubMed     Text format     Abstract available


  253. ZHANG J, Wong KY, Clark AL, Cleland JG, et al
    Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling.
    Int J Cardiol. 2017 Jan 27. pii: S0167-5273(17)30557.
    PubMed     Text format     Abstract available


  254. SWEDBERG K, Bohm M, Borer JS, Ford I, et al
    Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al.
    Int J Cardiol. 2017 Jan 23. pii: S0167-5273(16)34108.
    PubMed     Text format    


  255. BOTTO GL, Padeletti L, Covino G, Pieragnoli P, et al
    Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)33105.
    PubMed     Text format     Abstract available


  256. NAGAO K, Tamura A, Morimoto T, Shimamura K, et al
    Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course.
    Int J Cardiol. 2017 Jan 15. pii: S0167-5273(16)33698.
    PubMed     Text format     Abstract available


  257. ECHEVERRIA LE, Rojas LZ, Calvo LS, Roa ZM, et al
    Profiles of cardiovascular biomarkers according to severity stages of Chagas cardiomyopathy.
    Int J Cardiol. 2017;227:577-582.
    PubMed     Text format     Abstract available


  258. DI LULLO L, Bellasi A, Russo D, Cozzolino M, et al
    Cardiorenal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment.
    Int J Cardiol. 2017;227:143-150.
    PubMed     Text format     Abstract available


  259. STANKOVIC I, Neskovic AN, Lainscak M
    Physical and psychological status of patients with COPD and impaired LVEF: Two bads don't make a good.
    Int J Cardiol. 2017;227:249-250.
    PubMed     Text format    


  260. RE F, Zachara E, Avella A, Baratta P, et al
    Dissecting functional impairment in hypertrophic cardiomyopathy by dynamic assessment of diastolic reserve and outflow obstruction: A combined cardiopulmonary-echocardiographic study.
    Int J Cardiol. 2017;227:743-750.
    PubMed     Text format     Abstract available


  261. ZHANG X, Cheng HJ, Zhou P, Kitzman DW, et al
    Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.
    Int J Cardiol. 2017 Jan 10. pii: S0167-5273(16)33227.
    PubMed     Text format     Abstract available


  262. KISHIMOTO S, Kajikawa M, Maruhashi T, Iwamoto Y, et al
    Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(16)32405.
    PubMed     Text format     Abstract available


  263. ZYMLINSKI R, Sokolski M, Siwolowski P, Biegus J, et al
    Elevated troponin I level assessed by a new high-sensitive assay and the risk of poor outcomes in patients with acute heart failure.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30031.
    PubMed     Text format     Abstract available


  264. KONTOGEORGOS S, Thunstrom E, Johansson MC, Fu M, et al
    Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30080.
    PubMed     Text format     Abstract available


  265. MARTINEZ F, Martinez-Ibanez L, Pichler G, Ruiz A, et al
    Multimorbidity and acute heart failure in internal medicine.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30039.
    PubMed     Text format     Abstract available


  266. VON BIBRA H, Strohle A, St John Sutton M, Worm N, et al
    Dietary therapy in heart failure with preserved ejection fraction and/or left ventricular diastolic dysfunction in patients with metabolic syndrome.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30022.
    PubMed     Text format     Abstract available


  267. HARJOLA P, Boyd J, Tarvasmaki T, Mattila J, et al
    The impact of emergency medical services in acute heart failure.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(17)30036.
    PubMed     Text format     Abstract available


  268. GORI M, Volterrani M, Piepoli M, Senni M, et al
    Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs.
    Int J Cardiol. 2017;226:136-140.
    PubMed     Text format     Abstract available


  269. MOLLACE V, Gliozzi M, Capuano A, Rossi F, et al
    Modulation of RAAS-natriuretic peptides in the treatment of HF: Old guys and newcomers.
    Int J Cardiol. 2017;226:126-131.
    PubMed     Text format     Abstract available


    December 2016
  270. YANG Y, Huang WL, Yang J, Yang J, et al
    5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure.
    Int J Cardiol. 2016 Dec 29. pii: S0167-5273(16)34194.
    PubMed     Text format    


  271. KORATALA A, Jain A, Kazory A
    Ultrafiltration does provide more efficient decongestion compared to conventional treatment for acute heart failure.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)34131.
    PubMed     Text format    


  272. LARSSON SC, Wallin A, Wolk A
    Contrasting association between alcohol consumption and risk of myocardial infarction and heart failure: Two prospective cohorts.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)33141.
    PubMed     Text format     Abstract available


  273. PEARSON MJ, Smart NA
    Effect of exercise training on endothelial function in heart failure patients: A systematic review meta-analysis.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)32418.
    PubMed     Text format     Abstract available


  274. YOUNES A, Al-Kindi SG, Alajaji W, Mackall JA, et al
    Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)32654.
    PubMed     Text format     Abstract available


  275. CORREALE M, Carpagnano GE, Brunetti ND, Forte L, et al
    Respiratory drive in patients with chronic heart failure and central sleep apnea: Data from the Daunia Heart Failure Registry.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34823.
    PubMed     Text format    


  276. SANCHEZ-GIL J, Manzano L, Flather M, Formiga F, et al
    Combining heart rate and systolic blood pressure to improve risk stratification in older patients with heart failure: Findings from the RICA Registry.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34527.
    PubMed     Text format     Abstract available


  277. KATAOKA H
    Vascular expansion during worsening of heart failure: Effects on clinical features and its determinants.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34547.
    PubMed     Text format     Abstract available


  278. LIN YH, Kuo CC, Wu KK
    Reply to letter: "5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure".
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34776.
    PubMed     Text format    


  279. ASANO R, Kajimoto K, Oka T, Sugiura R, et al
    Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34539.
    PubMed     Text format     Abstract available


  280. XANTHOPOULOS A, Giamouzis G, Tryposkiadis K, Paraskevopoulou E, et al
    A simple score for early risk stratification in acute heart failure.
    Int J Cardiol. 2016 Dec 22. pii: S0167-5273(16)34584.
    PubMed     Text format     Abstract available


  281. LIN TY, Chen CY, Huang YB
    Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34589.
    PubMed     Text format     Abstract available


  282. IWAKAMI N, Nagai T, Furukawa TA, Sugano Y, et al
    Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34552.
    PubMed     Text format     Abstract available


  283. SEGUCHI O, Hisamatsu E, Nakano A, Nakajima S, et al
    Low partial pressure of end-tidal carbon dioxide predicts left ventricular assist device implantation in patients with advanced chronic heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34593.
    PubMed     Text format     Abstract available


  284. CHEN Y, Cai L, Du Z, Xu J, et al
    Dipstick proteinuria is a prognostic indicator of short-term mortality in patients with heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34587.
    PubMed     Text format     Abstract available


  285. IKEDA Y, Ishii S, Fujita T, Iida Y, et al
    Prognostic impact of intestinal wall thickening in hospitalized patients with heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34551.
    PubMed     Text format     Abstract available


  286. OKABE T, Yakushiji T, Kido T, Oyama Y, et al
    Relationship between worsening renal function and long-term cardiovascular mortality in heart failure patients.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34592.
    PubMed     Text format     Abstract available


  287. KOELL B, Zotter-Tufaro C, Duca F, Kammerlander AA, et al
    Fluid status and outcome in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34570.
    PubMed     Text format     Abstract available


  288. WANNAMETHEE SG, Whincup PH, Papacosta O, Lennon L, et al
    Associations between blood coagulation markers, NT-proBNP and risk of incident heart failure in older men: The British Regional Heart Study.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34544.
    PubMed     Text format     Abstract available


  289. FONSECA R, Otahal P, Galligan J, Neilson S, et al
    Association of survival time with transthoracic echocardiography in stable patients with heart failure: Is routine follow-up ever appropriate?
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34529.
    PubMed     Text format     Abstract available


  290. OMAR HR, Guglin M
    Acute systolic heart failure with normal admission BNP: clinical features and outcomes.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34558.
    PubMed     Text format     Abstract available


  291. AGRA BERMEJO RM, Gonzalez Ferreiro R, Varela Roman A, Gomez Otero I, et al
    Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure.
    Int J Cardiol. 2016 Dec 19. pii: S0167-5273(16)34557.
    PubMed     Text format     Abstract available


  292. HONDA S, Nagai T, Anzai T
    Reply to "delirium in heart failure".
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34253.
    PubMed     Text format    


    November 2016
  293. ASCHAUER S, Zotter-Tufaro C, Duca F, Kammerlander A, et al
    Modes of death in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016;228:422-426.
    PubMed     Text format     Abstract available


  294. AREVALO-LORIDO JC, Carretero-Gomez J, Manzano-Espinosa L
    Reply to the Letter to Editor "Hyposmolarity may be also associated with worse outcomes in patients with heart failure".
    Int J Cardiol. 2016 Nov 17. pii: S0167-5273(16)33930.
    PubMed     Text format    


  295. BERARDINI A, Biagini E, Saia F, Stolfo D, et al
    Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure?
    Int J Cardiol. 2016;228:191-197.
    PubMed     Text format     Abstract available


  296. SHEN Y, Du K
    Hyposmolarity may be also associated with worse outcomes in patients with heart failure.
    Int J Cardiol. 2016 Nov 12. pii: S0167-5273(16)32987.
    PubMed     Text format    


  297. OMAR HR, Guglin M
    Mitral annulus diameter is the main echocardiographic correlate of S3 gallop in acute heart failure.
    Int J Cardiol. 2016;228:834-836.
    PubMed     Text format    


  298. FUKUTA H, Goto T, Wakami K, Ohte N, et al
    The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies.
    Int J Cardiol. 2016;228:4-10.
    PubMed     Text format     Abstract available


  299. LEE YC, Chang CH, Dong YH, Lin JW, et al
    Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study.
    Int J Cardiol. 2016;228:1007-1014.
    PubMed     Text format     Abstract available


  300. MIZZACI CC, Porfirio GJ, Vilela AT, Guillhen JC, et al
    Ivabradine as adjuvant treatment for chronic heart failure.
    Int J Cardiol. 2016;227:43-50.
    PubMed     Text format     Abstract available


  301. MENG Y, Liu X, Liu J, Cheng X, et al
    A prospective study on the impact of heart rate control achieved with metoprolol on cardiac performance, motor function and quality of life in Chinese chronic heart failure patients.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33574.
    PubMed     Text format     Abstract available


  302. SINNING C, Kempf T, Schwarzl M, Lanfermann S, et al
    Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33567.
    PubMed     Text format     Abstract available


  303. ADACHI H, Katsuyama H, Yanai H
    The low dose (7.5mg/day) pioglitazone is beneficial to the improvement in metabolic parameters without weight gain and an increase of risk for heart failure.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33586.
    PubMed     Text format    


  304. ZHENG YR, Ye LF, Cen XJ, Lin JY, et al
    Low NT-proBNP levels: An early sign for the diagnosis of ischemic heart failure.
    Int J Cardiol. 2016;228:666-671.
    PubMed     Text format     Abstract available


  305. HAJDUSEK P, Kotrc M, Kautzner J, Melenovsky V, et al
    Heart rate response to exercise in heart failure patients: The prognostic role of metabolic-chronotropic relation and heart rate recovery.
    Int J Cardiol. 2016;228:588-593.
    PubMed     Text format     Abstract available


  306. ALAGIAKRISHNAN K, Mah D, Dyck JR, Senthilselvan A, et al
    Comparison of two commonly used clinical cognitive screening tests to diagnose mild cognitive impairment in heart failure with the golden standard European Consortium Criteria.
    Int J Cardiol. 2016;228:558-562.
    PubMed     Text format     Abstract available


  307. GOGGINS WB, Chan EY
    A study of the short-term associations between hospital admissions and mortality from heart failure and meteorological variables in Hong Kong: Weather and heart failure in Hong Kong.
    Int J Cardiol. 2016;228:537-542.
    PubMed     Text format     Abstract available


  308. AGRA RM, Varela-Roman A, Gonzalez-Ferreiro R, Vinuela JE, et al
    Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure.
    Int J Cardiol. 2016;228:488-494.
    PubMed     Text format     Abstract available


  309. MUNIBARI AN, Al-Motarreb A, Al-Sagheer N, Hadi HA, et al
    Clinical characteristics and outcomes of Yemeni patients with acute heart failure aged 50years or younger: Data from Gulf Acute Heart Failure Registry (Gulf CARE).
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)32093.
    PubMed     Text format     Abstract available


  310. AL-KHATEEB M, Qureshi WT, Odeh R, Ahmed AM, et al
    The impact of digoxin on mortality in patients with chronic systolic heart failure: A propensity-matched cohort study.
    Int J Cardiol. 2016;228:214-218.
    PubMed     Text format     Abstract available


  311. OTAKI Y, Watanabe T, Kinoshita D, Yokoyama M, et al
    Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
    Int J Cardiol. 2016;228:151-157.
    PubMed     Text format     Abstract available


  312. KULARATNA S, Byrnes J, Chan YK, Carrington MJ, et al
    Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions.
    Int J Cardiol. 2016;227:172-176.
    PubMed     Text format     Abstract available


  313. TSAI MY, Hu WL, Lin CC, Lee YC, et al
    Prescription pattern of Chinese herbal products for heart failure in Taiwan: A population-based study.
    Int J Cardiol. 2016;228:90-96.
    PubMed     Text format     Abstract available


  314. STRAUSS E, Supinski W, Radziemski A, Oszkinis G, et al
    Is hyperhomocysteinemia a causal factor for heart failure? The impact of the functional variants of MTHFR and PON1 on ischemic and non-ischemic etiology.
    Int J Cardiol. 2016;228:37-44.
    PubMed     Text format     Abstract available


  315. KWOK CS, Wong CW, Rushton CA, Ahmed F, et al
    Ultrafiltration for acute decompensated cardiac failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;228:122-128.
    PubMed     Text format     Abstract available


  316. STOLLBERGER C, Schneider B
    Concerns about the ESC heart failure guidelines.
    Int J Cardiol. 2016;228:707-708.
    PubMed     Text format    


  317. USZKO-LENCER NH, Frankenstein L, Spruit MA, Maeder MT, et al
    Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33581.
    PubMed     Text format     Abstract available


  318. TAMARGO J, Rosano GM, Delpon E, Ruilope L, et al
    Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33583.
    PubMed     Text format     Abstract available


  319. ULRICH SM, Lehner A, Birnbaum J, Heckel S, et al
    Safety of optical coherence tomography in pediatric heart transplant patients.
    Int J Cardiol. 2016;228:205-208.
    PubMed     Text format     Abstract available


  320. JACOB J, Tost J, Miro O, Herrero P, et al
    Impact of chronic obstructive pulmonary disease on clinical course after an episode of acute heart failure. EAHFE-COPD study.
    Int J Cardiol. 2016 Nov 8. pii: S0167-5273(16)33443.
    PubMed     Text format     Abstract available


  321. HIRAKAWA K, Yamamuro M, Uemura T, Takashio S, et al
    Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis.
    Int J Cardiol. 2016;228:881-885.
    PubMed     Text format     Abstract available


  322. GIULIANO C, Karahalios A, Neil C, Allen J, et al
    The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure - A meta-analysis.
    Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33469.
    PubMed     Text format     Abstract available


  323. LAM PH, Dooley DJ, Inampudi C, Arundel C, et al
    Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.
    Int J Cardiol. 2016 Nov 4. pii: S0167-5273(16)33408.
    PubMed     Text format     Abstract available


  324. KAZORY A
    The lower risk of de novo heart failure associated with peritoneal dialysis; the timing does matter.
    Int J Cardiol. 2016 Nov 2. pii: S0167-5273(16)33043.
    PubMed     Text format    


  325. OLDENBURG O, Coats A
    CSA Is Not Beneficial Long Term in Heart Failure Patients with Reduced Ejection Fraction.
    Int J Cardiol. 2016 Nov 2. pii: S0167-5273(16)33404.
    PubMed     Text format     Abstract available


    October 2016
  326. ARIMURA T, Saku K, Kakino T, Nishikawa T, et al
    Intravenous electrical vagal nerve stimulation prior to coronary reperfusion in a canine ischemia-reperfusion model markedly reduces infarct size and prevents subsequent heart failure.
    Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33267.
    PubMed     Text format     Abstract available


  327. BRENNER S, Christa M, Berliner D, Deubner N, et al
    Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction.
    Int J Cardiol. 2016 Oct 28. pii: S0167-5273(16)33245.
    PubMed     Text format     Abstract available


  328. WANG IK, Lin CL, Sung FC
    Lower risk of de novo congestive heart failure in peritoneal dialysis patients compared with hemodialysis patients.
    Int J Cardiol. 2016 Oct 27. pii: S0167-5273(16)33116.
    PubMed     Text format    


  329. METRA M, Carubelli V, Ravera A, Stewart Coats AJ, et al
    Heart failure 2016: still more questions than answers.
    Int J Cardiol. 2016 Oct 26. pii: S0167-5273(16)33156.
    PubMed     Text format     Abstract available


  330. TOYODA S, Haruyama A, Inami S, Amano H, et al
    Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure.
    Int J Cardiol. 2016;226:71-76.
    PubMed     Text format     Abstract available


  331. CIARKA A, Edwards L, Nilsson J, Stehlik J, et al
    Trends in the use of mechanical circulatory support as a bridge to heart transplantation across different age groups.
    Int J Cardiol. 2016 Oct 19. pii: S0167-5273(16)32375.
    PubMed     Text format    


  332. CHENG S, Wang H, Lu M, Cui C, et al
    The value of CMR for determination of heart failure etiology: An unusual case with histology validation.
    Int J Cardiol. 2016;226:38-41.
    PubMed     Text format    


  333. SAVARESE G, Donal E, Hage C, Oger E, et al
    Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
    Int J Cardiol. 2016;226:65-70.
    PubMed     Text format     Abstract available


  334. BOULOGNE M, Sadoune M, Launay JM, Baudet M, et al
    Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction.
    Int J Cardiol. 2016;226:53-59.
    PubMed     Text format     Abstract available


  335. CUI X, Zhou J, Jin X, Zhou J, et al
    Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents.
    Int J Cardiol. 2016 Oct 17. pii: S0167-5273(16)33012.
    PubMed     Text format     Abstract available


  336. STAFYLAS P, Farmakis D, Kourlaba G, Giamouzis G, et al
    The heart failure pandemic: The clinical and economic burden in Greece.
    Int J Cardiol. 2016 Oct 17. pii: S0167-5273(16)33013.
    PubMed     Text format     Abstract available


  337. ACANFORA D, Scicchitano P, Casucci G, Lanzillo B, et al
    Exercise training effects on elderly and middle-age patients with chronic heart failure after acute decompensation: A randomized, controlled trial.
    Int J Cardiol. 2016;225:313-323.
    PubMed     Text format     Abstract available


  338. REYNOLDS JO, Quick AP, Wang Q, Beavers DL, et al
    Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca2+ release.
    Int J Cardiol. 2016;225:371-380.
    PubMed     Text format     Abstract available


  339. CARUBELLI V, Cotter G, Davison B, Gishe J, et al
    In-hospital worsening heart failure in patients admitted for acute heart failure.
    Int J Cardiol. 2016;225:353-361.
    PubMed     Text format     Abstract available


  340. OMAR HR, Guglin M
    Community acquired versus hospital acquired hyponatremia in acute heart failure: Association with clinical characteristics and outcomes.
    Int J Cardiol. 2016;225:247-249.
    PubMed     Text format    


  341. SAITOH M, Dos Santos MR, Anker M, Anker SD, et al
    Neuromuscular electrical stimulation for muscle wasting in heart failure patients.
    Int J Cardiol. 2016;225:200-205.
    PubMed     Text format     Abstract available


    September 2016
  342. BERKVENS CP, Mommersteeg PM
    Letter to the editor: Is an ischemic etiology especially detrimental for women with heart failure?
    Int J Cardiol. 2016 Sep 30. pii: S0167-5273(16)32162.
    PubMed     Text format    


  343. MASUTANI S, Kuwata S, Kurishima C, Iwamoto Y, et al
    Ventricular-vascular dynamics in pediatric patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016;225:306-312.
    PubMed     Text format     Abstract available


  344. BROWN LA, Boos CJ
    Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.
    Int J Cardiol. 2016 Sep 30. pii: S0167-5273(16)32512.
    PubMed     Text format     Abstract available


  345. BATLLE M, Campos B, Farrero M, Cardona M, et al
    Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP.
    Int J Cardiol. 2016;225:113-119.
    PubMed     Text format     Abstract available


  346. SALZANO A, Marra AM, Ferrara F, Arcopinto M, et al
    Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;225:1-3.
    PubMed     Text format    


  347. ROCHA A, Arbex FF, Alencar MC, Sperandio PA, et al
    Physiological and sensory consequences of exercise oscillatory ventilation in heart failure-COPD.
    Int J Cardiol. 2016;224:447-453.
    PubMed     Text format     Abstract available


  348. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Int J Cardiol. 2016;225:30-36.
    PubMed     Text format     Abstract available


  349. SIMIONIUC A, Carluccio E, Ghio S, Rossi A, et al
    Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients.
    Int J Cardiol. 2016;224:416-423.
    PubMed     Text format     Abstract available


  350. GHOSH RK, Ball S, Prasad V, Gupta A, et al
    Depression in heart failure: Intricate relationship, pathophysiology and most updated evidence of interventions from recent clinical studies.
    Int J Cardiol. 2016;224:170-177.
    PubMed     Text format     Abstract available


  351. TANAKA S, Kamiya K, Masuda T, Hamazaki N, et al
    Low ankle brachial index is associated with the magnitude of impaired walking endurance in patients with heart failure.
    Int J Cardiol. 2016;224:400-405.
    PubMed     Text format     Abstract available


  352. MINAMI Y, Kajimoto K, Sato N, Hagiwara N, et al
    End-stage renal disease patients on chronic maintenance hemodialysis in a hospitalized acute heart failure cohort: Prevalence, clinical characteristics, therapeutic options, and mortality.
    Int J Cardiol. 2016;224:267-270.
    PubMed     Text format    


  353. CHUGH Y, Faillace RT
    The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
    Int J Cardiol. 2016;224:431-436.
    PubMed     Text format     Abstract available


  354. VAN DEN BERGE JC, Akkerhuis MK, Constantinescu AA, Kors JA, et al
    Temporal trends in long-term mortality of patients with acute heart failure: Data from 1985-2008.
    Int J Cardiol. 2016;224:456-460.
    PubMed     Text format     Abstract available


  355. CULIC V, Busic Z, Busic M
    Circulating sex hormones, alcohol consumption and echocardiographic parameters of cardiac function in men with heart failure.
    Int J Cardiol. 2016;224:245-251.
    PubMed     Text format    


  356. HOLLINGWORTH W, Biswas M, Maishman RL, Dayer MJ, et al
    The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.
    Int J Cardiol. 2016;224:132-138.
    PubMed     Text format     Abstract available


  357. LAINSCAK M, Vitale C, Seferovic P, Spoletini I, et al
    Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure.
    Int J Cardiol. 2016;224:191-198.
    PubMed     Text format     Abstract available


  358. KAMIYA M, Kamiya M, Tsuzuki M, Tanaka T, et al
    Prevention of re-hospitalization by home-based intervention and adaptive servo-ventilation therapy in a patient who experienced repeated hospitalization for decompensated heart failure.
    Int J Cardiol. 2016;224:96-98.
    PubMed     Text format    


  359. VEGTER EL, Schmitter D, Hagemeijer Y, Ovchinnikova ES, et al
    Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.
    Int J Cardiol. 2016;224:231-239.
    PubMed     Text format     Abstract available


  360. MASSON S, Barlera S, Colotta F, Magnoli M, et al
    A low plasma 1,25(OH)2 vitamin D/PTH (1-84) ratio predicts worsening of renal function in patients with chronic heart failure.
    Int J Cardiol. 2016;224:220-225.
    PubMed     Text format     Abstract available


  361. PALAZZUOLI A, Testani JM, Ruocco G, Pellegrini M, et al
    Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
    Int J Cardiol. 2016;224:213-219.
    PubMed     Text format     Abstract available


  362. HICKEY A, Suna J, Marquart L, Denaro C, et al
    Improving medication titration in heart failure by embedding a structured medication titration plan.
    Int J Cardiol. 2016;224:99-106.
    PubMed     Text format     Abstract available


    August 2016
  363. ARAMBULA-GARZA E, Castillo-Martinez L, Gonzalez-Islas D, Orea-Tejeda A, et al
    Association of cardiac cachexia and atrial fibrillation in heart failure patients.
    Int J Cardiol. 2016;223:863-866.
    PubMed     Text format     Abstract available


  364. GAJANANA D, Shah M, Junpapart P, Romero-Corral A, et al
    Mortality in systolic heart failure revisited: Ischemic versus non-ischemic cardiomyopathy.
    Int J Cardiol. 2016;224:15-17.
    PubMed     Text format    


  365. RUSSO G, Cioffi G, Pulignano G, Barbati G, et al
    Reasons why patients suffering from chronic heart failure at very low risk for mortality die.
    Int J Cardiol. 2016;223:947-952.
    PubMed     Text format     Abstract available


  366. FAYSSOIL A
    Which place for ivabradine in Duchenne muscular dystrophy with heart failure?
    Int J Cardiol. 2016;223:768-769.
    PubMed     Text format    


  367. HUIS IN 'T VELD AE, Van Vliet AG, Spruijt OA, Handoko ML, et al
    CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension.
    Int J Cardiol. 2016;223:723-728.
    PubMed     Text format     Abstract available


  368. NUNEZ J, Teruel A, Quinones-Torrelo C, Garcia-Blas S, et al
    Continuous ambulatory peritoneal dialysis as a promising therapy for light chain amyloidosis with congestive heart failure.
    Int J Cardiol. 2016;223:807-809.
    PubMed     Text format    


  369. DEMISSEI BG, Postmus D, Liu LC, Cleland JG, et al
    Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial.
    Int J Cardiol. 2016;223:967-975.
    PubMed     Text format     Abstract available


  370. KAWADA T
    Risk of hemodialysis against peritoneal dialysis for chronic heart failure in patients with end-stage renal disease.
    Int J Cardiol. 2016;223:360.
    PubMed     Text format    


  371. BAKIR M, Nelson MD, Jones E, Li Q, et al
    Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.
    Int J Cardiol. 2016;223:936-939.
    PubMed     Text format     Abstract available


  372. GIANNINI C, Fiorelli F, Colombo A, De Carlo M, et al
    Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy.
    Int J Cardiol. 2016;223:574-580.
    PubMed     Text format     Abstract available


  373. PRENNER SB, Oskouie S, Shah SJ, Sauer AJ, et al
    Repolarization heterogeneity, diastolic dysfunction, and cardiovascular outcomes in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;223:116-117.
    PubMed     Text format    


  374. DE BENEDITTIS G, Rosa GD, D'Ettorre E, Piscitelli P, et al
    Effect of Ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: A chance for slowing progression of heart failure?
    Int J Cardiol. 2016;223:286-288.
    PubMed     Text format    


  375. OMAR HR, Guglin M
    Characteristics and outcomes of patients with acute systolic heart failure discharged within 48hours: A qualification for "observation status" hospital admission.
    Int J Cardiol. 2016;223:129-132.
    PubMed     Text format    


  376. LINDGREN MP, Smith JG, Li X, Sundquist J, et al
    Sibling risk of hospitalization for heart failure - A nationwide study.
    Int J Cardiol. 2016;223:379-384.
    PubMed     Text format     Abstract available


  377. XING F, Hu X, Jiang J, Ma Y, et al
    A meta-analysis of low-dose dopamine in heart failure.
    Int J Cardiol. 2016;222:1003-1011.
    PubMed     Text format     Abstract available


  378. ZHONG Y, Wang N
    Different etiological factors of heart failure may have diverse levels of biomarkers.
    Int J Cardiol. 2016;223:82.
    PubMed     Text format    


  379. LAL S, Turner L, Powell C, Wilson M, et al
    Improvements in left ventricular ejection fraction and quality of life in patients with heart failure who undergo coronary artery bypass surgery.
    Int J Cardiol. 2016;222:671-673.
    PubMed     Text format    


  380. RUIZ G, Andrey JL, Puerto JL, Escobar MA, et al
    Prognosis of heart failure with preserved ejection fraction treated with beta-blockers: A propensity matched study in the community.
    Int J Cardiol. 2016;222:594-602.
    PubMed     Text format     Abstract available


  381. ROCHA BM, Menezes Falcao L
    Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death.
    Int J Cardiol. 2016;223:1035-1044.
    PubMed     Text format     Abstract available


  382. ODDOU I, Jeung MY, Roy C, El Ghannudi S, et al
    Giant right coronary artery to coronary sinus fistula associated with severe tricuspid regurgitation and persistent left superior vena cava.
    Int J Cardiol. 2016;223:40-42.
    PubMed     Text format    


  383. BOJARCZUK J, Josiak K, Kasztura M, Kustrzycka-Kratochwil D, et al
    Iron deficiency in heart failure: Impact on response to cardiac resynchronization therapy.
    Int J Cardiol. 2016;222:133-134.
    PubMed     Text format    


  384. LIN YH, Kuo CC, Lee CM, Chou CH, et al
    5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility.
    Int J Cardiol. 2016;222:895-900.
    PubMed     Text format     Abstract available


  385. DAMLUJI AA, Macon C, Fox A, Garcia G, et al
    The association between in-hospital hemoglobin changes, cardiovascular events, and mortality in acute decompensated heart failure: Results from the ESCAPE trial.
    Int J Cardiol. 2016;222:531-537.
    PubMed     Text format     Abstract available


  386. REYES EB, Ha JW, Firdaus I, Ghazi AM, et al
    Heart failure across Asia: Same healthcare burden but differences in organization of care.
    Int J Cardiol. 2016;223:163-167.
    PubMed     Text format     Abstract available


    July 2016
  387. HONDA S, Nagai T, Sugano Y, Okada A, et al
    Prevalence, determinants, and prognostic significance of delirium in patients with acute heart failure.
    Int J Cardiol. 2016;222:521-527.
    PubMed     Text format     Abstract available


  388. LEE H, Kim TH, Leem J
    Acupuncture for heart failure: A systematic review of clinical studies.
    Int J Cardiol. 2016;222:321-331.
    PubMed     Text format     Abstract available


  389. LU ML, Davila CD, Shah M, Wheeler DS, et al
    Marital status and living condition as predictors of mortality and readmissions among African Americans with heart failure.
    Int J Cardiol. 2016;222:313-318.
    PubMed     Text format     Abstract available


  390. KAJIMOTO K, Minami Y, Sato N, Takano T, et al
    Serum sodium concentration, blood urea nitrogen, and outcomes in patients hospitalized for acute decompensated heart failure.
    Int J Cardiol. 2016;222:195-201.
    PubMed     Text format     Abstract available


  391. CHEN MC, Chang TH, Chang JP, Huang HD, et al
    Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation.
    Int J Cardiol. 2016;222:148-154.
    PubMed     Text format     Abstract available


  392. FARMAKIS D, Alvarez J, Gal TB, Brito D, et al
    Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.
    Int J Cardiol. 2016;222:303-312.
    PubMed     Text format     Abstract available


  393. MARTIN-SANCHEZ FJ, Christ M, Miro O, Peacock WF, et al
    Practical approach on frail older patients attended for acute heart failure.
    Int J Cardiol. 2016;222:62-71.
    PubMed     Text format     Abstract available


  394. BEKFANI T, Pellicori P, Morris DA, Ebner N, et al
    Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.
    Int J Cardiol. 2016;222:41-46.
    PubMed     Text format     Abstract available


  395. BIELECKA-DABROWA A, Sakowicz A, Misztal M, von Haehling S, et al
    Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
    Int J Cardiol. 2016;221:1073-1080.
    PubMed     Text format     Abstract available


  396. CORNELIS J, Beckers P, Taeymans J, Vrints C, et al
    Comparing exercise training modalities in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:867-876.
    PubMed     Text format     Abstract available


  397. OMAR HR, Guglin M
    Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.
    Int J Cardiol. 2016;221:1116-1122.
    PubMed     Text format     Abstract available


  398. MADELAIRE C, Schou M, Nelveg-Kristensen KE, Schmiegelow M, et al
    Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.
    Int J Cardiol. 2016;221:944-950.
    PubMed     Text format     Abstract available


  399. WANG M, Ding H, Kang J, Hu K, et al
    Association between polymorphisms of the HSPB7 gene and Cheyne-Stokes respiration with central sleep apnea in patients with dilated cardiomyopathy and congestive heart failure.
    Int J Cardiol. 2016;221:926-931.
    PubMed     Text format     Abstract available


  400. LAOUTARIS ID, Adamopoulos S, Manginas A, Panagiotakos DB, et al
    Inspiratory work capacity is more severely depressed than inspiratory muscle strength in patients with heart failure: Novel applications for inspiratory muscle training.
    Int J Cardiol. 2016;221:622-626.
    PubMed     Text format     Abstract available


  401. EGUCHI A, Iwasaku T, Okuhara Y, Naito Y, et al
    Long-term administration of tolvaptan increases myocardial remodeling and mortality via exacerbation of congestion in mice heart failure model after myocardial infarction.
    Int J Cardiol. 2016;221:302-309.
    PubMed     Text format     Abstract available


  402. HUYNH QL, Negishi K, Blizzard L, Saito M, et al
    Mild cognitive impairment predicts death and readmission within 30days of discharge for heart failure.
    Int J Cardiol. 2016;221:212-217.
    PubMed     Text format     Abstract available


  403. AUFFRET V, Leurent G, Gilard M, Hacot JP, et al
    Incidence, timing, predictors and impact of acute heart failure complicating ST-segment elevation myocardial infarction in patients treated by primary percutaneous coronary intervention.
    Int J Cardiol. 2016;221:433-442.
    PubMed     Text format     Abstract available


  404. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Piccolo R, Galasso G, et al
    Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Int J Cardiol. 2016;221:359-363.
    PubMed     Text format     Abstract available


  405. BHATT KN, Kalogeropoulos AP, Dunbar SB, Butler J, et al
    Depression in heart failure: Can PHQ-9 help?
    Int J Cardiol. 2016;221:246-250.
    PubMed     Text format     Abstract available


  406. AREVALO-LORIDO JC, Gomez JC, Formiga F, Conde-Martel A, et al
    High serum osmolarity at admission determines a worse outcome in patients with heart failure: Is a new target emerging?
    Int J Cardiol. 2016;221:238-242.
    PubMed     Text format     Abstract available


  407. MATSUE Y, Suzuki M, Torii S, Yamaguchi S, et al
    Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction.
    Int J Cardiol. 2016;221:188-193.
    PubMed     Text format     Abstract available


  408. BANERJEE P, Motiwala A, Mustafa HM, Gani MA, et al
    Does left ventricular diastolic dysfunction progress through stages? Insights from a community heart failure study.
    Int J Cardiol. 2016;221:850-854.
    PubMed     Text format     Abstract available


  409. TROMP J, Meyer S, Mentz RJ, O'Connor CM, et al
    Acute heart failure in the young: Clinical characteristics and biomarker profiles.
    Int J Cardiol. 2016;221:1067-1072.
    PubMed     Text format     Abstract available


  410. JEWISS D, Ostman C, Smart NA
    The effect of resistance training on clinical outcomes in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:674-681.
    PubMed     Text format     Abstract available


  411. GUIZONI DM, Oliveira-Junior SA, Noor SL, Pagan LU, et al
    Effects of late exercise on cardiac remodeling and myocardial calcium handling proteins in rats with moderate and large size myocardial infarction.
    Int J Cardiol. 2016;221:406-412.
    PubMed     Text format     Abstract available


  412. BANFI C, Agostoni P
    Surfactant protein B: From biochemistry to its potential role as diagnostic and prognostic marker in heart failure.
    Int J Cardiol. 2016;221:456-462.
    PubMed     Text format     Abstract available


  413. PERCIACCANTE A, Coralli A, Bianucci R
    Has Saint Anthony of Padua suffered from congestive heart failure?
    Int J Cardiol. 2016;221:110-111.
    PubMed     Text format    


  414. AMIR O, Azzam ZS, Gaspar T, Faranesh-Abboud S, et al
    Validation of remote dielectric sensing (ReDS) technology for quantification of lung fluid status: Comparison to high resolution chest computed tomography in patients with and without acute heart failure.
    Int J Cardiol. 2016;221:841-846.
    PubMed     Text format     Abstract available


  415. SAIRAKU A, Yoshida Y, Nakano Y, Hirayama H, et al
    Don't expect left ventricular reverse remodeling after cardiac resynchronization therapy in patients with systolic heart failure and atrioventricular block: A multicenter study.
    Int J Cardiol. 2016;221:597-600.
    PubMed     Text format     Abstract available


    June 2016
  416. CEBRIAN-CUENCA AM, Orozco-Beltran D, Navarro-Perez J, Franch-Nadal J, et al
    Saxagliptin and risk of heart failure hospitalization: Concern or miscalculation?
    Int J Cardiol. 2016;220:573-574.
    PubMed     Text format    


  417. CORNELIS J, Vrints C, Vanroy C, Vissers D, et al
    Letter by Cornelis et al. regarding article, "Exercise oscillatory ventilation in heart failure".
    Int J Cardiol. 2016;220:759-760.
    PubMed     Text format    


  418. MAKUBI A, Hage C, Sartipy U, Lwakatare J, et al
    Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF).
    Int J Cardiol. 2016;220:750-758.
    PubMed     Text format     Abstract available


  419. VAZIR A, Simpkin VL, Marino P, Ludman A, et al
    Association of haemodynamic changes measured by serial central venous saturation during ultrafiltration for acutely decompensated heart failure with diuretic resistance and change in renal function.
    Int J Cardiol. 2016;220:618-622.
    PubMed     Text format     Abstract available


  420. EDWARDS MK, Loprinzi PD
    Sedentary behavior & health-related quality of life among congestive heart failure patients.
    Int J Cardiol. 2016;220:520-523.
    PubMed     Text format     Abstract available


  421. PIOTROWICZ E, Piepoli MF, Jaarsma T, Lambrinou E, et al
    Telerehabilitation in heart failure patients: The evidence and the pitfalls.
    Int J Cardiol. 2016;220:408-413.
    PubMed     Text format     Abstract available


  422. PARK SY, Trinity JD, Gifford JR, Diakos NA, et al
    Mitochondrial function in heart failure: The impact of ischemic and non-ischemic etiology.
    Int J Cardiol. 2016;220:711-717.
    PubMed     Text format     Abstract available


  423. NUNEZ J, Nunez E, Minana G, Carratala A, et al
    Serum neprilysin and recurrent hospitalizations after acute heart failure.
    Int J Cardiol. 2016;220:742-744.
    PubMed     Text format    


  424. ZWISLER AD, Norton RJ, Dean SG, Dalal H, et al
    Home-based cardiac rehabilitation for people with heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:963-969.
    PubMed     Text format     Abstract available


  425. FURIHATA T, Kinugawa S, Fukushima A, Takada S, et al
    Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure.
    Int J Cardiol. 2016;220:483-487.
    PubMed     Text format     Abstract available


  426. SINIORAKIS EE, Arapi SM, Panta SG, Pyrgakis VN, et al
    Emergency department triage of acute heart failure triggered by pneumonia; when an intensive care unit is needed?
    Int J Cardiol. 2016;220:479-482.
    PubMed     Text format     Abstract available


  427. MOREIRA-SILVA S, Urbano J, Moura MC, Ferreira-Coimbra J, et al
    Liver cytolysis in acute heart failure: What does it mean? Clinical profile and outcomes of a prospective hospital cohort.
    Int J Cardiol. 2016;221:422-427.
    PubMed     Text format     Abstract available


  428. KATZ A, Maor E, Leor J, Klempfner R, et al
    Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
    Int J Cardiol. 2016;221:198-204.
    PubMed     Text format     Abstract available


  429. OMAR HR, Guglin M
    Longitudinal BNP follow-up as a marker of treatment response in acute heart failure: Relationship with objective markers of decongestion.
    Int J Cardiol. 2016;221:167-170.
    PubMed     Text format     Abstract available


  430. OZAWA K, Funabashi N, Sugiura A, Kobayashi Y, et al
    Layer specific strain measurement and its relationship to heart failure indicators in systemic autoimmune disorder patients: A multi-layer transthoracic echocardiography study.
    Int J Cardiol. 2016;220:693-699.
    PubMed     Text format    


  431. DENG J, Zhong Q
    Advanced research on the microRNA mechanism in heart failure.
    Int J Cardiol. 2016;220:61-64.
    PubMed     Text format     Abstract available


  432. GU J, Fan YQ, Han ZH, Fan L, et al
    Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.
    Int J Cardiol. 2016;220:56-60.
    PubMed     Text format     Abstract available


  433. PAN WQ, He YH, Su Q, Yang J, et al
    Association of decreased serum vasostatin-2 level with ischemic chronic heart failure and with MACE in 3-year follow-up: Vasostatin-2 prevents heart failure in myocardial infarction rats.
    Int J Cardiol. 2016;221:1-11.
    PubMed     Text format     Abstract available


  434. OMAR HR, Guglin M
    Hypothermia is an independent predictor of short and intermediate term mortality in acute systolic heart failure: Insights from the ESCAPE trial.
    Int J Cardiol. 2016;220:729-733.
    PubMed     Text format     Abstract available


  435. CHANG CH, Chang YC, Lin JW, Caffrey JL, et al
    No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan.
    Int J Cardiol. 2016;220:14-20.
    PubMed     Text format     Abstract available


  436. BERTON G, Cordiano R, Cavuto F, Bagato F, et al
    Heart failure in women and men during acute coronary syndrome and long-term cardiovascular mortality (the ABC-3* Study on Heart Disease) (*Adria, Bassano, Conegliano, and Padova Hospitals).
    Int J Cardiol. 2016;220:538-543.
    PubMed     Text format     Abstract available


  437. SOKORELI I, de Vries JJ, Riistama JM, Pauws SC, et al
    Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure.
    Int J Cardiol. 2016;220:202-207.
    PubMed     Text format     Abstract available


  438. FARMAKIS D, Filippatos G, Parissis J, Karavidas A, et al
    Structured discharge instructions for hospitalized heart failure patients to improve guideline implementation and patient outcomes.
    Int J Cardiol. 2016;220:143-145.
    PubMed     Text format    


  439. RUIGOMEZ A, Michel A, Martin-Perez M, Garcia Rodriguez LA, et al
    Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality.
    Int J Cardiol. 2016;220:855-861.
    PubMed     Text format     Abstract available


  440. ERTEKIN E, van Hagen IM, Salam AM, Ruys TP, et al
    Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology.
    Int J Cardiol. 2016;220:131-136.
    PubMed     Text format     Abstract available


  441. RAFFA GM, Di Gesaro G, Sciacca S, Tuzzolino F, et al
    Heart transplant program at IRCCS-ISMETT: Impact of mechanical circulatory support on pre- and post -transplant survival.
    Int J Cardiol. 2016;219:358-361.
    PubMed     Text format     Abstract available


  442. SALAMANCA-BAUTISTA P, Conde-Martel A, Aramburu-Bodas O, Formiga F, et al
    Precipitating factors of heart failure admission: Differences related to age and left ventricular ejection fraction.
    Int J Cardiol. 2016;219:150-155.
    PubMed     Text format     Abstract available


  443. ORSZULAK M, Mizia-Stec K, Siennicka A, Goscinska-Bis K, et al
    Differences of psychological features in patients with heart failure with regard to gender and aetiology - Results of a CAPS-LOCK-HF (Complex Assessment of Psychological Status Located in Heart Failure) study.
    Int J Cardiol. 2016;219:380-386.
    PubMed     Text format     Abstract available


  444. MARCINKIEWICZ-SIEMION M, Ciborowski M, Kretowski A, Musial WJ, et al
    Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
    Int J Cardiol. 2016;219:156-163.
    PubMed     Text format     Abstract available


  445. ZUPAN MEZNAR A, Berden P, Lainscak M
    Left ventricular metastasis of soft tissue sarcoma causing heart failure: Presentation of two cases.
    Int J Cardiol. 2016;219:119-120.
    PubMed     Text format    


  446. WANG S, Liu M, Fang F, Shang Q, et al
    Prognostic value of acoustic cardiography in patients with chronic heart failure.
    Int J Cardiol. 2016;219:121-126.
    PubMed     Text format     Abstract available


    May 2016
  447. D'ONOFRIO A, Iuliano A, De Simone A, Pecora D, et al
    Electrical remodeling after cardiac resynchronization therapy and its relationship with the anatomical remodeling.
    Int J Cardiol. 2016;211:86-7.
    PubMed     Text format    


  448. NIEMINEN MS, Buerke M, Cohen-Solal A, Costa S, et al
    The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.
    Int J Cardiol. 2016;218:150-157.
    PubMed     Text format     Abstract available


  449. BAUM C, Ojeda FM, Wild PS, Rzayeva N, et al
    Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population.
    Int J Cardiol. 2016;218:298-304.
    PubMed     Text format     Abstract available


  450. KUBE J, Ebner N, Jankowska EA, Rozentryt P, et al
    The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
    Int J Cardiol. 2016;219:84-91.
    PubMed     Text format     Abstract available


  451. GEORGIOPOULOU VV, Tang WH, Giamouzis G, Li S, et al
    Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium.
    Int J Cardiol. 2016;218:136-143.
    PubMed     Text format     Abstract available


  452. OMAR HR, Guglin M
    Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes.
    Int J Cardiol. 2016;218:120-125.
    PubMed     Text format     Abstract available


  453. COGLIATI C, Casazza G, Ceriani E, Torzillo D, et al
    Lung ultrasound and short-term prognosis in heart failure patients.
    Int J Cardiol. 2016;218:104-108.
    PubMed     Text format     Abstract available


  454. AL-KINDI SG, ElAmm C, Ginwalla M, Mehanna E, et al
    Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.
    Int J Cardiol. 2016;218:43-46.
    PubMed     Text format     Abstract available


  455. DE ANGELIS A, Cappetta D, Piegari E, Rinaldi B, et al
    Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;217:69-79.
    PubMed     Text format     Abstract available


  456. KANG J, Park J, Lee JM, Park JJ, et al
    The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: A meta-analysis of randomized clinical trials.
    Int J Cardiol. 2016;218:12-22.
    PubMed     Text format     Abstract available


  457. VOLTERRANI M, Iellamo F, Senni M, Piepoli MF, et al
    Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition.
    Int J Cardiol. 2016 May 7. pii: S0167-5273(16)30876.
    PubMed     Text format     Abstract available


  458. VAN RIET EE, Hoes AW, Limburg A, Landman MA, et al
    Effect of training general practitioners in drug treatment of newly detected heart failure patients with reduced or preserved ejection fraction: A cluster randomized trial.
    Int J Cardiol. 2016;217:174-182.
    PubMed     Text format     Abstract available


  459. RIM TH, Oh J, Kang SM, Kim SS, et al
    Association between retinal vein occlusion and risk of heart failure: A 12-year nationwide cohort study.
    Int J Cardiol. 2016;217:122-127.
    PubMed     Text format     Abstract available


    April 2016
  460. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
    ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
    Int J Cardiol. 2016;217:128-134.
    PubMed     Text format     Abstract available


  461. BOSSEAU C, Donal E
    Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients.
    Int J Cardiol. 2016 Apr 22. pii: S0167-5273(16)30278.
    PubMed     Text format    


  462. KOULAOUZIDIS G, Iakovidis DK, Clark AL
    Telemonitoring predicts in advance heart failure admissions.
    Int J Cardiol. 2016;216:78-84.
    PubMed     Text format     Abstract available


  463. HIDALGO FJ, Anguita M, Castillo JC, Rodriguez S, et al
    Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
    Int J Cardiol. 2016;217:7-11.
    PubMed     Text format     Abstract available


  464. ONOUE Y, Izumiya Y, Hanatani S, Tanaka T, et al
    A simple sarcopenia screening test predicts future adverse events in patients with heart failure.
    Int J Cardiol. 2016;215:301-306.
    PubMed     Text format     Abstract available


  465. KINOSHITA K, Kawai M, Minai K, Ogawa K, et al
    Potent influence of obesity on suppression of plasma B-type natriuretic peptide levels in patients with acute heart failure: An approach using covariance structure analysis.
    Int J Cardiol. 2016;215:283-290.
    PubMed     Text format     Abstract available


  466. CARROLL R, Mudge A, Suna J, Denaro C, et al
    Prescribing and up-titration in recently hospitalized heart failure patients attending a disease management program.
    Int J Cardiol. 2016;216:121-127.
    PubMed     Text format     Abstract available


  467. DAMATTO RL, Lima AR, Martinez PF, Cezar MD, et al
    Myocardial myostatin in spontaneously hypertensive rats with heart failure.
    Int J Cardiol. 2016;215:384-387.
    PubMed     Text format     Abstract available


  468. KLOPPE A, Lawo T, Mijic D, Schiedat F, et al
    Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration.
    Int J Cardiol. 2016;209:291-5.
    PubMed     Text format     Abstract available


  469. CANDEL FJ, Matesanz M, Martin-Sanchez FJ, Gonzalez Del Castillo JM, et al
    Monitoring of high-dose fosfomycin guided by NT-proBNP.
    Int J Cardiol. 2016;209:131-2.
    PubMed     Text format    


  470. POURAFKARI L, Wang CK, Schwartz M, Nader ND, et al
    Does shock index provide prognostic information in acute heart failure?
    Int J Cardiol. 2016;215:140-142.
    PubMed     Text format    


  471. SHIRAISHI M, Murakami T, Nawa T, Kobayashi H, et al
    Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant.
    Int J Cardiol. 2016;215:127-128.
    PubMed     Text format    


  472. KIVIKKO M, Pollesello P, Tarvasmaki T, Sarapohja T, et al
    Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.
    Int J Cardiol. 2016;215:26-31.
    PubMed     Text format     Abstract available


  473. BRISCO MA, Zile MR, Ter Maaten JM, Hanberg JS, et al
    The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.
    Int J Cardiol. 2016;215:521-526.
    PubMed     Text format     Abstract available


  474. VIEIRA JL, Guimaraes GV, de Andre PA, Saldiva PH, et al
    Effects of reducing exposure to air pollution on submaximal cardiopulmonary test in patients with heart failure: Analysis of the randomized, double-blind and controlled FILTER-HF trial.
    Int J Cardiol. 2016;215:92-97.
    PubMed     Text format     Abstract available


  475. GASTELURRUTIA P, Cuba-Gyllensten I, Lupon J, Zamora E, et al
    Wearable vest for pulmonary congestion tracking and prognosis in heart failure: A pilot study.
    Int J Cardiol. 2016;215:77-79.
    PubMed     Text format    


  476. SLAWUTA A, Mazur G, Malecka B, Gajek J, et al
    Permanent His bundle pacing - An optimal treatment method in heart failure patients with AF and narrow QRS.
    Int J Cardiol. 2016;214:451-452.
    PubMed     Text format    


  477. FENG YX, Yang LJ, Li T, Dong HW, et al
    Association between elevated D-dimer levels and adverse outcome in patients with acute heart failure.
    Int J Cardiol. 2016;214:415-416.
    PubMed     Text format    


  478. WANG J, Hu X, Jiang H
    MSCs modified with HO-1 gene transplantation: A novel therapeutic approach for attenuating heart failure.
    Int J Cardiol. 2016;214:159-160.
    PubMed     Text format    


  479. FUKUTA H, Goto T, Wakami K, Ohte N, et al
    The effect of statins on mortality in heart failure with preserved ejection fraction: a meta-analysis of propensity score analyses.
    Int J Cardiol. 2016;214:301-306.
    PubMed     Text format     Abstract available


  480. SMITH S, Rossignol P, Willis S, Zannad F, et al
    Neural modulation for hypertension and heart failure.
    Int J Cardiol. 2016;214:320-330.
    PubMed     Text format     Abstract available


  481. LOMBARDI C, Fanfulla F, Parati G
    Treatment of central sleep apnea in heart failure patients: Benefit or harm?
    Int J Cardiol. 2016;214:254-255.
    PubMed     Text format    


  482. ZIAEI F, Zaman M, Rasoul D, Gorantla RS, et al
    The prevalence of atrial fibrillation amongst heart failure patients increases with age.
    Int J Cardiol. 2016;214:410-411.
    PubMed     Text format    


    March 2016
  483. WANG J, Hu X, Jiang H
    HDAC inhibition: A novel therapeutic approach for attenuating heart failure by suppressing cardiac remodeling.
    Int J Cardiol. 2016;214:41-42.
    PubMed     Text format    


  484. LOPRINZI PD
    Physical activity, weight status, and mortality among congestive heart failure patients.
    Int J Cardiol. 2016;214:92-94.
    PubMed     Text format     Abstract available


  485. MINANA G, Rumiz E, Palau P, Valero E, et al
    Plasma neutrophil gelatinase-associated lipocalin and long-term mortality in patients with acute heart failure and normal renal function.
    Int J Cardiol. 2016;214:51-53.
    PubMed     Text format    


  486. KOTECHA D
    Letter: Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients - Response.
    Int J Cardiol. 2016 Mar 25. pii: S0167-5273(16)30529.
    PubMed     Text format    


  487. OH PC, Koh KK
    Recurrent stress-induced cardiomyopathy presented with acute decompensated heart failure.
    Int J Cardiol. 2016;212:307-309.
    PubMed     Text format    


  488. GUO WQ, Li L
    Angiotensin converting enzyme inhibitors for heart failure with reduced ejection fraction or left ventricular dysfunction: A complementary network meta-analyses.
    Int J Cardiol. 2016;214:10-12.
    PubMed     Text format    


  489. NEGRI F, Gamba A, Belgrano M, Bussani R, et al
    Hypertrophic Cardiomyopathy: An unexpected finding in a surgical variant of Heterotopic Heart Transplantation.
    Int J Cardiol. 2016;214:121-122.
    PubMed     Text format    


  490. ROSSI F, Mascolo A, Mollace V
    The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure.
    Int J Cardiol. 2016 Mar 23. pii: S0167-5273(16)30502.
    PubMed     Text format     Abstract available


  491. RADULOVIC B, Potocnjak I, Dokoza Teresak S, Trbusic M, et al
    Hypochloraemia as a predictor of developing hyponatraemia and poor outcome in acute heart failure patients.
    Int J Cardiol. 2016;212:237-241.
    PubMed     Text format     Abstract available


  492. BACURAU AV, Jannig PR, de Moraes WM, Cunha TF, et al
    Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice.
    Int J Cardiol. 2016;214:137-147.
    PubMed     Text format     Abstract available


  493. OHUCHI H, Hayama Y, Negishi J, Noritake K, et al
    Heart failure with preserved right ventricular ejection fraction in postoperative adults with congenital heart disease: A subtype of severe right ventricular pathophysiology.
    Int J Cardiol. 2016;212:223-231.
    PubMed     Text format     Abstract available


  494. KUNDU A, Sardar P, Ghosh S, Patel P, et al
    Risk of heart failure with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;212:203-205.
    PubMed     Text format    


  495. KAJIMOTO K, Sato N, Takano T
    Association between age, time after hospitalization, and survival among patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2016;212:151-153.
    PubMed     Text format    


  496. LOPRINZI PD
    Physical activity with alanine aminotransferase and gamma-glutamyltransferase among congestive heart failure patients.
    Int J Cardiol. 2016;212:61-62.
    PubMed     Text format    


  497. DURMAZ O, Olgun Kucuk H, Kucuk U
    Intricate associations between heart failure, depression and vitamin D.
    Int J Cardiol. 2016;212:121.
    PubMed     Text format    


  498. SU JL, Zhang SG, Gao RJ, Han QF, et al
    Red cell distribution width is a predictor of mortality in patients with chronic heart failure.
    Int J Cardiol. 2016;212:79-81.
    PubMed     Text format    


  499. YI X, Li X, Jiang X
    Carabin: Endogenous calcineurin inhibitor, a potential diagnostic and therapeutic target for cardiac hypertrophy in heart failure.
    Int J Cardiol. 2016;212:57-58.
    PubMed     Text format    


  500. ELEUTERI E, Di Stefano A, Giordano A, Corra U, et al
    Prognostic value of angiopoietin-2 in patients with chronic heart failure.
    Int J Cardiol. 2016;212:364-368.
    PubMed     Text format     Abstract available


  501. YOSHIHISA A, Suzuki S, Kanno Y, Takiguchi M, et al
    Prognostic significance of periodic leg movements during sleep in heart failure patients.
    Int J Cardiol. 2016;212:11-13.
    PubMed     Text format    


  502. LOPRINZI PD
    Implications of light-intensity physical activity in improving health-related quality of life among congestive heart failure patients.
    Int J Cardiol. 2016;212:16-17.
    PubMed     Text format    


  503. STEWART S, Riegel B, Boyd C, Ahamed Y, et al
    Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
    Int J Cardiol. 2016;212:1-10.
    PubMed     Text format     Abstract available


  504. JONSSON A, Hallberg AC, Edner M, Lund LH, et al
    A comprehensive assessment of the association between anemia, clinical covariates and outcomes in a population-wide heart failure registry.
    Int J Cardiol. 2016;211:124-131.
    PubMed     Text format    


  505. GANGA HV, Jantz J, Puppala VK
    The impact of iron deficiency on exercise capacity in chronic heart failure patients.
    Int J Cardiol. 2016 Mar 2. pii: S0167-5273(16)30122.
    PubMed     Text format    


  506. PARENICA J, Kala P, Pavkova MG, Tomandl J, et al
    Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study
    Int J Cardiol. 2016;211:96-104.
    PubMed     Text format     Abstract available


  507. KONGWATCHARAPONG J, Dilokthornsakul P, Nathisuwan S, Phrommintikul A, et al
    Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials.
    Int J Cardiol. 2016;211:88-95.
    PubMed     Text format     Abstract available


  508. BOONMAN-DE WINTER LJ, van Stel HF, Hoes AW, Landman MJ, et al
    Health status of older patients with type 2 diabetes and screen-detected heart failure is significantly lower than those without.
    Int J Cardiol. 2016;211:79-83.
    PubMed     Text format    


  509. LEE JF, Barrett-O'Keefe Z, Nelson AD, Garten RS, et al
    Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;211:14-21.
    PubMed     Text format     Abstract available


  510. LAINSCAK M, Coats AJ
    The PARADIGM of ARNI's: Assessing reasons for non-implementation in heart failure.
    Int J Cardiol. 2016;212:187-189.
    PubMed     Text format     Abstract available


  511. JOSEPH S, Costanzo MR
    A novel therapeutic approach for central sleep apnea: Phrenic nerve stimulation by the remede(R) System.
    Int J Cardiol. 2016;206 Suppl:S28-34.
    PubMed     Text format     Abstract available


  512. FLINTA I, Ponikowski P
    Relationship between central sleep apnea and Cheyne-Stokes Respiration.
    Int J Cardiol. 2016;206 Suppl:S8-12.
    PubMed     Text format     Abstract available


  513. KHAYAT RN, Abraham WT
    Current treatment approaches and trials in central sleep apnea.
    Int J Cardiol. 2016;206 Suppl:S22-7.
    PubMed     Text format     Abstract available


    February 2016
  514. NAUGHTON MT
    Epidemiology of central sleep apnoea in heart failure.
    Int J Cardiol. 2016 Feb 26. pii: S0167-5273(16)30359.
    PubMed     Text format     Abstract available


  515. COATS AJ, Shewan LG
    Measuring therapeutic efficacy in the treatment of CSA in patients with heart failure.
    Int J Cardiol. 2016 Feb 24. pii: S0167-5273(16)30356.
    PubMed     Text format     Abstract available


  516. COATS AJ, Abraham WT
    Central sleep apnoea in heart failure - An important issue for the modern heart failure cardiologist.
    Int J Cardiol. 2016 Feb 24. pii: S0167-5273(16)30353.
    PubMed     Text format    


  517. CORRA U
    Exercise oscillatory ventilation in heart failure.
    Int J Cardiol. 2016 Feb 23. pii: S0167-5273(16)30355.
    PubMed     Text format     Abstract available


  518. VASSILIOU VS, Patel HC, Rosen SD, Auger D, et al
    Left atrial dilation in patients with heart failure and preserved ejection fraction: Insights from cardiovascular magnetic resonance.
    Int J Cardiol. 2016;210:158-160.
    PubMed     Text format    


  519. KOUNIS NG, Soufras GD, Lianas D, Patsouras N, et al
    Heparin-induced thrombocytopenia, allergy to heparins, heart failure, thrombi, and the Kounis syndrome.
    Int J Cardiol. 2016 Feb 20. pii: S0167-5273(16)30340.
    PubMed     Text format    


  520. TANAKA A, Nakamura T, Sato E, Node K, et al
    Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome.
    Int J Cardiol. 2016;210:1-3.
    PubMed     Text format    


  521. CHATTERJEE NA, Singh JP, Szymonifka J, Deano RC, et al
    Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.
    Int J Cardiol. 2016;205:43-9.
    PubMed     Text format     Abstract available


  522. ABDUL-RAHIM AH, MacIsaac RL, Jhund PS, Petrie MC, et al
    Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.
    Int J Cardiol. 2016;209:310-316.
    PubMed     Text format     Abstract available


  523. KONDO M, Kohno T, Kohsaka S, Fukuoka R, et al
    Enhanced oxidative stress is associated with sleep-disordered breathing and obesity in patients with heart failure.
    Int J Cardiol. 2016;209:133-135.
    PubMed     Text format    


  524. MARRA AM, Arcopinto M, Salzano A, Bobbio E, et al
    Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure.
    Int J Cardiol. 2016;209:114-117.
    PubMed     Text format    


  525. KAWADA T
    Antidepressant use, clinical depression and mortality in patients with heart failure.
    Int J Cardiol. 2016;209:68-69.
    PubMed     Text format    


  526. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
    Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
    Int J Cardiol. 2016;209:1-6.
    PubMed     Text format     Abstract available


  527. ARMENI P, Boscolo PR, Tarricone R, Capodanno D, et al
    Real-world cost effectiveness of MitraClip combined with Medical Therapy Versus Medical therapy alone in patients with moderate or severe mitral regurgitation.
    Int J Cardiol. 2016;209:153-160.
    PubMed     Text format     Abstract available


  528. MENET A, Guyomar Y, Ennezat PV, Graux P, et al
    Prognostic value of left ventricular reverse remodeling and performance improvement after cardiac resynchronization therapy: A prospective study.
    Int J Cardiol. 2016;204:6-11.
    PubMed     Text format     Abstract available


    January 2016
  529. VROMEN T, Kraal JJ, Kuiper J, Spee RF, et al
    The influence of training characteristics on the effect of aerobic exercise training in patients with chronic heart failure: A meta-regression analysis.
    Int J Cardiol. 2016;208:120-127.
    PubMed     Text format     Abstract available


  530. KAWADA T
    Survival risk of salivary cortisol and serum N-terminal pro-hormone B-type natriuretic peptide in patients with systolic heart failure.
    Int J Cardiol. 2016 Jan 25. pii: S0167-5273(16)30193.
    PubMed     Text format    


  531. BEHNES M, Bertsch T, Weiss C, Ahmad-Nejad P, et al
    Response to letter: Device therapy and aldosterone antagonists in the prognosis of heart failure.
    Int J Cardiol. 2016 Jan 21. pii: S0167-5273(16)30198.
    PubMed     Text format    


  532. POLLESELLO P, Papp Z, Papp JG
    Calcium sensitizers: What have we learned over the last 25 years?
    Int J Cardiol. 2016;203:543-8.
    PubMed     Text format     Abstract available


  533. HUANG Y, Mai L, Cai X, Hu Y, et al
    Stem cell therapy for heart disease-Meta-analysis may be misleading.
    Int J Cardiol. 2016;203:351-2.
    PubMed     Text format    


  534. KITADA S, Schulze PC, Jin Z, Clerkin KJ, et al
    Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Int J Cardiol. 2016;203:929-35.
    PubMed     Text format     Abstract available


  535. SINNING C, Kozlik-Feldmann R, Demir C, Blankenberg S, et al
    Long-term course of a patient with congenital corrected transposition of the great arteries and dextrocardia--The Fisher King.
    Int J Cardiol. 2016;203:436-7.
    PubMed     Text format    


  536. TSCHOPE C, Van Linthout S, Spillmann F, Klein O, et al
    Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF.
    Int J Cardiol. 2016;203:1061-6.
    PubMed     Text format    


  537. FUNG E, Fong MW, Correa AJ, Yoon AJ, et al
    Fulminant eosinophilic myocarditis following ICD implantation in a patient with undisclosed nickel allergy.
    Int J Cardiol. 2016;203:1018-9.
    PubMed     Text format    


  538. MADIAS JE
    Takotsubo syndrome/QTc interval prolongation/myocardial edema/cardiac sympathetic denervation/cardiac arrhythmias: A quintet needing exploration.
    Int J Cardiol. 2016;203:259-61.
    PubMed     Text format    


  539. NUNEZ J, Dominguez E, Ramon JM, Nunez E, et al
    Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;207:365-367.
    PubMed     Text format    


  540. PIPER SE, de Courcey J, Sherwood RA, Amin-Youssef GF, et al
    Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: A pilot study.
    Int J Cardiol. 2016;207:279-281.
    PubMed     Text format    


  541. MUNOZ MA, Real J, Del Val JL, Vinyoles E, et al
    Determinants of survival and hospitalization in older, heart failure patients receiving home healthcare.
    Int J Cardiol. 2016;207:145-149.
    PubMed     Text format     Abstract available


  542. JOHANSSON P, Alehagen U, van der Wal MH, Svensson E, et al
    Vitamin D levels and depressive symptoms in patients with chronic heart failure.
    Int J Cardiol. 2016;207:185-189.
    PubMed     Text format     Abstract available


  543. ONO R, Funabashi N, Takaoka H, Ozawa K, et al
    Massive myocardial aneurysm due to inferior to posterior myocardial infarction complicated with right-sided heart failure in a 36-year-old male.
    Int J Cardiol. 2016;209:98-102.
    PubMed     Text format    


  544. MICHEL A, Martin-Perez M, Ruigomez A, Garcia Rodriguez LA, et al
    Incidence and risk factors for severe renal impairment after first diagnosis of heart failure: A cohort and nested case-control study in UK general practice.
    Int J Cardiol. 2016;207:252-257.
    PubMed     Text format     Abstract available


  545. LOPRINZI PD
    Physical activity and peripheral arterial disease among patients with coronary artery disease or congestive heart failure.
    Int J Cardiol. 2016;207:110-111.
    PubMed     Text format    


  546. CURCIO A, Cascini GL, De Rosa S, Pasceri E, et al
    I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation.
    Int J Cardiol. 2016;207:107-109.
    PubMed     Text format    


  547. ALHAJ EK
    Can unilateral adrenalectomy be an option in modulating autonomic nervous system in heart failure?
    Int J Cardiol. 2016;207:50-52.
    PubMed     Text format     Abstract available


  548. CARTER P, Reynolds J, Carter A, Potluri S, et al
    The impact of psychiatric comorbidities on the length of hospital stay in patients with heart failure.
    Int J Cardiol. 2016;207:292-296.
    PubMed     Text format     Abstract available


  549. DIXON DL, Bersten AD, Lawrence MD, Bihari S, et al
    Lung surfactant in chronic heart failure patients.
    Int J Cardiol. 2016;207:213-214.
    PubMed     Text format    


  550. KAYA H, Beton O, Yilmaz MB
    Atrial fibrillation and D dimer levels for patients with acute decompensated heart failure.
    Int J Cardiol. 2016;207:136.
    PubMed     Text format    


  551. LIU M, Fang F, Luo XX, Shlomo BH, et al
    Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study.
    Int J Cardiol. 2016;206:122-126.
    PubMed     Text format     Abstract available


  552. IMRAN TF, Shah R, Ha AS, Thomas R, et al
    Heart failure associated with small molecule tyrosine kinase inhibitors.
    Int J Cardiol. 2016;206:110-111.
    PubMed     Text format    


  553. LOPRINZI PD
    Objectively-measured physical activity and sleep apnea among congestive heart failure patients.
    Int J Cardiol. 2016;206:82-83.
    PubMed     Text format    


  554. BAVISHI C, Khan AR, Ather S
    Reply to the letter "Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality".
    Int J Cardiol. 2016;206:56-57.
    PubMed     Text format    


  555. FAN Z, Yang J, Yang J, Yang C, et al
    HDAC inhibition: A novel therapeutic approach for atherosclerosis.
    Int J Cardiol. 2016;202:722-3.
    PubMed     Text format    


  556. DONAZZAN L, Rigolli M, De Simone V, Bergamini C, et al
    Cardiac resynchronization therapy: Twelve-month effects of echocardiographic atrio-ventricular and inter-ventricular delay optimization. Rationale and design of the CARTEDO trial.
    Int J Cardiol. 2016;202:185-7.
    PubMed     Text format    


  557. HUANG JH, Lin YK, Hsieh MH, Chiu WC, et al
    Age and thyroid hormone replacement delays the recovery from amiodarone-induced hypothyroidism.
    Int J Cardiol. 2016;202:561-3.
    PubMed     Text format    


  558. LAINSCAK M, von Haehling S, Anker SD
    PURE muscle and more.
    Int J Cardiol. 2016;202:446-7.
    PubMed     Text format    


  559. SANTAS E, Nunez J
    Prognostic implications of pericardial effusion: The importance of underlying etiology.
    Int J Cardiol. 2016;202:407.
    PubMed     Text format    


  560. SOMMESE L, Valverde CA, Blanco P, Castro MC, et al
    Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate.
    Int J Cardiol. 2016;202:394-406.
    PubMed     Text format     Abstract available


    December 2015
  561. XIE W, Zheng F, Song X, Zhong B, et al
    Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Int J Cardiol. 2015;205:65-71.
    PubMed     Text format     Abstract available


  562. HIGASHI K, Murakami T, Ishikawa Y, Itoi T, et al
    Efficacy and safety of tolvaptan for pediatric patients with congestive heart failure. Multicenter survey in the working group of the Japanese Society of PEdiatric Circulation and Hemodynamics (J-SPECH).
    Int J Cardiol. 2015;205:37-42.
    PubMed     Text format     Abstract available


  563. DOKAINISH H, Teo K, Zhu J, Roy A, et al
    Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study.
    Int J Cardiol. 2015;204:133-141.
    PubMed     Text format     Abstract available


  564. EBNER N, Jankowska EA, Ponikowski P, Lainscak M, et al
    The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
    Int J Cardiol. 2015;205:6-12.
    PubMed     Text format     Abstract available


  565. CAPUANO A, Scavone C, Vitale C, Sportiello L, et al
    Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
    Int J Cardiol. 2015;200:15-9.
    PubMed     Text format     Abstract available


    November 2015
  566. DEMISSEI BG, Cleland JG, O'Connor CM, Metra M, et al
    Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients.
    Int J Cardiol. 2015;204:164-171.
    PubMed     Text format     Abstract available


  567. BANERJEE P
    Heart failure with preserved ejection fraction: A clinical crisis.
    Int J Cardiol. 2015;204:198-199.
    PubMed     Text format     Abstract available


  568. YOKOKAWA T, Sugano Y, Shimouchi A, Shibata A, et al
    A case of acute decompensated heart failure evaluated by series of exhaled acetone concentrations as noninvasive biomarker of heart failure severity.
    Int J Cardiol. 2015;204:112-113.
    PubMed     Text format    


  569. LUPON J, Sanders-van Wijk S, Januzzi JL, de Antonio M, et al
    Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study.
    Int J Cardiol. 2015;204:242-247.
    PubMed     Text format     Abstract available


  570. LEVICK SP, Melendez GC
    Targeting substance P and relaxin: A future combination therapy approach for heart failure?
    Int J Cardiol. 2015;204:154-155.
    PubMed     Text format    


  571. CONSUEGRA-SANCHEZ L, Jaulent-Huertas L, Vicente-Gilabert M, Escudero-Garcia G, et al
    Heart failure complicating acute myocardial infarction. Does the time of presentation matter?
    Int J Cardiol. 2015;204:48-50.
    PubMed     Text format    


  572. MINAMI Y, Haruki S, Jujo K, Itani R, et al
    Elevated D-dimer levels predict an adverse outcome in hospitalized patients with acute decompensated heart failure.
    Int J Cardiol. 2015;204:42-44.
    PubMed     Text format    


  573. GELLEN B, Canoui-Poitrine F, Boyer L, Drouot X, et al
    Apnea-hypopnea and desaturations in heart failure with reduced ejection fraction: Are we aiming at the right target?
    Int J Cardiol. 2015;203:1022-1028.
    PubMed     Text format     Abstract available


  574. LOPRINZI PD
    The association of serum cotinine and congestive heart failure diagnosis among never smokers: Considerations by physical activity behavior.
    Int J Cardiol. 2015;203:1042-1043.
    PubMed     Text format    


  575. TARGHER G, Dauriz M, Tavazzi L, Temporelli PL, et al
    Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
    Int J Cardiol. 2015;203:587-593.
    PubMed     Text format    


  576. LOPRINZI PD
    The effects of free-living physical activity on mortality after congestive heart failure diagnosis.
    Int J Cardiol. 2015;203:598-599.
    PubMed     Text format    


  577. BRUNO N, Ter Maaten JM, Ovchinnikova ES, Vegter EL, et al
    MicroRNAs relate to early worsening of renal function in patients with acute heart failure.
    Int J Cardiol. 2015;203:564-569.
    PubMed     Text format     Abstract available


  578. PALAU P, Dominguez E, Nunez E, Sanchis J, et al
    Six-minute walk test in moderate to severe heart failure with preserved ejection fraction: Useful for functional capacity assessment?
    Int J Cardiol. 2015;203:800-802.
    PubMed     Text format    


  579. BOSCHETTO P, Vaccari A, Groccia R, Casimirri E, et al
    Forced expiratory volume in one second: Predicting return to work within 3months after chronic heart failure diagnosis.
    Int J Cardiol. 2015;203:798-799.
    PubMed     Text format    


  580. MUELLER KA, Schwille J, Vollmer S, Ehinger E, et al
    Prognostic impact of macrophage migration inhibitory factor in patients with non-ischemic heart failure undergoing endomyocardial biopsy.
    Int J Cardiol. 2015;203:656-659.
    PubMed     Text format    


  581. CORRA U, Agostoni P, Giordano A, Cattadori G, et al
    The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.
    Int J Cardiol. 2015;203:1067-1072.
    PubMed     Text format     Abstract available


  582. KITAMURA M, Mimura Y, Taniue H, Yoshitake K, et al
    Predictors of independent walking at hospital discharge in elderly heart failure patients.
    Int J Cardiol. 2015;203:609-611.
    PubMed     Text format    


  583. KOEHLER U, Kesper K, Timmesfeld N, Grimm W, et al
    Cheyne-Stokes respiration in patients with heart failure.
    Int J Cardiol. 2015;203:775-778.
    PubMed     Text format    


  584. LOPATIN YM, Rosano GM, Fragasso G, Lopaschuk GD, et al
    Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
    Int J Cardiol. 2015;203:909-915.
    PubMed     Text format     Abstract available


  585. BROUWERS C, Christensen SB, Damen NL, Denollet J, et al
    Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression.
    Int J Cardiol. 2015;203:867-873.
    PubMed     Text format     Abstract available


    October 2015
  586. MESSIAS LR, Messias AC, de Miranda SM, Wiefels CC, et al
    Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction.
    Int J Cardiol. 2015;203:900-902.
    PubMed     Text format    


  587. MAYER O JR, Seidlerova J, Vanek J, Karnosova P, et al
    The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Int J Cardiol. 2015;203:916-922.
    PubMed     Text format     Abstract available


  588. BOWEN TS, Eisenkolb S, Werner S, Schwarzer M, et al
    Inheriting a high aerobic fitness predisposes to skeletal muscle and endothelial dysfunction in chronic heart failure.
    Int J Cardiol. 2015;203:353-356.
    PubMed     Text format    


  589. EYUBOGLU M
    Device therapy and aldosterone antagonists in the prognosis of heart failure.
    Int J Cardiol. 2015 Oct 28. pii: S0167-5273(15)30763.
    PubMed     Text format    


  590. KOTECHA D, Chudasama R, Lane DA, Kirchhof P, et al
    Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.
    Int J Cardiol. 2015;203:660-666.
    PubMed     Text format     Abstract available


  591. ROBLEK T, Deticek A, Leskovar B, Suskovic S, et al
    Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trial.
    Int J Cardiol. 2015;203:647-652.
    PubMed     Text format     Abstract available


  592. NYMO SH, Ueland T, Askevold E, Dahl CP, et al
    Circulating nucleosomes in chronic heart failure.
    Int J Cardiol. 2015;203:742-743.
    PubMed     Text format    


  593. YANG J, Fan Z, Yang J, Yang C, et al
    Relaxin: A novel therapy for acute heart failure.
    Int J Cardiol. 2015 Oct 27. pii: S0167-5273(15)30760.
    PubMed     Text format    


  594. GEMES K, Janszky I, Ahnve S, Laszlo KD, et al
    Light-to-moderate drinking and incident heart failure - the Norwegian HUNT study.
    Int J Cardiol. 2015;203:553-560.
    PubMed     Text format     Abstract available


  595. BARRA S, Providencia R, Agarwal S
    Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?
    Int J Cardiol. 2015;203:184-186.
    PubMed     Text format    


  596. HE WM, Luo YT, Shui X, Liao XX, et al
    Critical appraisal of international guidelines on chronic heart failure: Can China AGREE?
    Int J Cardiol. 2015;203:111-114.
    PubMed     Text format    


  597. BEHNES M, Bertsch T, Weiss C, Ahmad-Nejad P, et al
    Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
    Int J Cardiol. 2015;203:398-406.
    PubMed     Text format    


  598. FARMAKIS D, Stafylas P, Giamouzis G, Maniadakis N, et al
    The medical and socioeconomic burden of heart failure: A comparative delineation with cancer.
    Int J Cardiol. 2015;203:279-281.
    PubMed     Text format     Abstract available


  599. LOURENCO P, Ribeiro A, Cunha FM, Pintalhao M, et al
    Is there a heart rate paradox in acute heart failure?
    Int J Cardiol. 2015;203:409-414.
    PubMed     Text format    


  600. HAMMER F, Deutschbein T, Marx A, Guder G, et al
    High evening salivary cortisol is an independent predictor of increased mortality risk in patients with systolic heart failure.
    Int J Cardiol. 2015;203:69-73.
    PubMed     Text format     Abstract available


  601. CHEN Y, Huang W, Huang Y, Hu Y, et al
    Beta-blockers treatment in heart failure with atrial fibrillation - Who should we believe?
    Int J Cardiol. 2015;203:60-61.
    PubMed     Text format    


  602. MA H, Wang X, Xie H, Sun C, et al
    Characterization of the cardiac venous system in heart failure patients using 256-slice CT.
    Int J Cardiol. 2015;203:447-448.
    PubMed     Text format    


  603. LIN YS, Tung TH, Wang J, Chen YF, et al
    Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Int J Cardiol. 2015;203:204-211.
    PubMed     Text format     Abstract available


  604. GUVENC TS, Ekmekci A, Sargin M, Orhan G, et al
    Rapid improvement of pulmonary hemodynamics following combined tadalafil and inotropic treatment in a patient with pulmonary hypertension secondary to left ventricular dysfunction.
    Int J Cardiol. 2015;203:212-213.
    PubMed     Text format    


  605. ZACHARIAS M, Joffe S, Konadu E, Meyer T, et al
    Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients.
    Int J Cardiol. 2015;202:918-921.
    PubMed     Text format     Abstract available


  606. BIRGY C, Bresson D, Duculescu E, Carpentier M, et al
    Rare and life-threatening cardiovascular complication of chronic thromboembolic pulmonary hypertension diagnosed by trans-thoracic echocardiography.
    Int J Cardiol. 2015;203:450-452.
    PubMed     Text format    


  607. PETERS S
    Focal form of left ventricular non-compaction cardiomyopathy with congestive form of heart failure.
    Int J Cardiol. 2015;202:879.
    PubMed     Text format    


  608. ZENGIN E, Sinning C, Schrage B, Mueller GC, et al
    Right heart failure in pregnant women with cyanotic congenital heart disease - The good, the bad and the ugly.
    Int J Cardiol. 2015;202:773-775.
    PubMed     Text format    


  609. SHIRAISHI Y, Sawano M, Kohno T, Nishiyama T, et al
    Validation of the Seattle Heart Failure Model in Japanese heart failure patients.
    Int J Cardiol. 2015;203:87-89.
    PubMed     Text format    


  610. HOPPER I, Skiba M, Windebank E, Brack J, et al
    Polypharmacy in heart failure - Is reducing medication safe?
    Int J Cardiol. 2015 Oct 9. pii: S0167-5273(15)30533.
    PubMed     Text format    


  611. CHEN J, Stein S, Molina M, Owens A, et al
    Right heart size in orthotopic heart transplant population: Influence of donor and recipient gender, race, and body surface area.
    Int J Cardiol. 2015;203:105-106.
    PubMed     Text format    


    September 2015
  612. MIZUNO A, Ohde S, Hayashi A, Nakamura M, et al
    The differences of advance decision making between hospitalized patients with heart failure and malignant disease.
    Int J Cardiol. 2015;202:649-651.
    PubMed     Text format    


  613. HUANG Y, Huang W, Hu Y
    Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality?
    Int J Cardiol. 2015 Sep 27. pii: S0167-5273(15)30521.
    PubMed     Text format    


  614. VICENZI M, Deboeck G, Faoro V, Loison J, et al
    Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.
    Int J Cardiol. 2015;202:736-740.
    PubMed     Text format     Abstract available


  615. WANG J, Fang F, Yip GW, Sanderson JE, et al
    Importance of chronotropic response and left ventricular long-axis function for exercise performance in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2015;202:339-343.
    PubMed     Text format     Abstract available


  616. ALTER P, Koczulla AR, Nell C, Figiel JH, et al
    Wall stress determines systolic and diastolic function - Characteristics of heart failure.
    Int J Cardiol. 2015;202:685-693.
    PubMed     Text format     Abstract available


  617. ZHANG J, Hobkirk J, Carroll S, Pellicori P, et al
    Exploring quality of life in patients with and without heart failure.
    Int J Cardiol. 2015;202:676-684.
    PubMed     Text format     Abstract available


  618. LINDE C, Curtis AB, Fonarow GC, Lee K, et al
    Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Int J Cardiol. 2015;202:349-355.
    PubMed     Text format     Abstract available


  619. FANG F, Liu W, Zhao YX, Yang Y, et al
    The patient's selection of PARACHUTE(R) endoventricular partitioning device: The important role of detailed echocardiography.
    Int J Cardiol. 2015;195:176-9.
    PubMed     Text format    


  620. GIANNONI A, Raglianti V, Mirizzi G, Taddei C, et al
    Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure.
    Int J Cardiol. 2015;202:200-206.
    PubMed     Text format     Abstract available


  621. DHOBLE A, Kashif M, Chakravarty T, Jilaihawi H, et al
    Transcatheter tricuspid valve replacement along with tricuspid paravalvular leak closure in a patient with severe right heart failure and previous transcatheter pulmonary valve replacement.
    Int J Cardiol. 2015;202:198-199.
    PubMed     Text format    


  622. ROBLES-MEZCUA A, Gonzalez-Cruces N, Ruiz-Salas A, Morcillo-Hidalgo L, et al
    Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction.
    Int J Cardiol. 2015;202:118-120.
    PubMed     Text format    


  623. PAREEK M, Nielsen ML, Leosdottir M, Nilsson PM, et al
    Response to the letter by Tomoyuki Kawada: Diastolic function, fasting plasma glucose and left ventricular mass index.
    Int J Cardiol. 2015;194:58-9.
    PubMed     Text format    


    August 2015
  624. KELLER-ROSS ML, Johnson BD, Carter RE, Joyner MJ, et al
    Improved Ventilatory Efficiency with Locomotor Muscle Afferent Inhibition is Strongly Associated with Leg Composition in Heart Failure.
    Int J Cardiol. 2015;202:159-166.
    PubMed     Text format     Abstract available


  625. SILVETTI S, Nieminen MS
    Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
    Int J Cardiol. 2015;202:138-143.
    PubMed     Text format     Abstract available


  626. SPINAR J, Jarkovsky J, Spinarova L, Mebazaa A, et al
    AHEAD score - Long-term risk classification in acute heart failure.
    Int J Cardiol. 2015;202:21-26.
    PubMed     Text format     Abstract available


  627. MAGRI D, Banfi C, Maruotti A, Farina S, et al
    Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective study.
    Int J Cardiol. 2015;201:394-399.
    PubMed     Text format     Abstract available


  628. KAWADA T
    Diastolic function, fasting plasma glucose and left ventricular mass index.
    Int J Cardiol. 2015;193:58.
    PubMed     Text format    


  629. BUSSEY CT, Hughes G, Saxena P, Galvin IF, et al
    Chamber-specific changes in calcium-handling proteins in the type 2 diabetic human heart with preserved ejection fraction.
    Int J Cardiol. 2015;193:53-5.
    PubMed     Text format    


  630. VAN ITERSON EH, Snyder EM, Joyner MJ, Johnson BD, et al
    Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitance.
    Int J Cardiol. 2015;201:384-393.
    PubMed     Text format     Abstract available


  631. DOEHNER W, Jankowska EA, Springer J, Lainscak M, et al
    Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.
    Int J Cardiol. 2015 Aug 11. pii: S0167-5273(15)30319.
    PubMed     Text format     Abstract available


  632. WEIDMANN ZM, Breidthardt T, Twerenbold R, Zusli C, et al
    Prediction of mortality using quantification of renal function in acute heart failure.
    Int J Cardiol. 2015;201:650-657.
    PubMed     Text format     Abstract available


  633. MARU S, Byrnes J, Carrington MJ, Chan YK, et al
    Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Frien
    Int J Cardiol. 2015;201:368-375.
    PubMed     Text format     Abstract available


  634. FARMAKIS D, Parissis J, Karavidas A, Karvounis C, et al
    In-hospital management of acute heart failure: Practical recommendations and future perspectives.
    Int J Cardiol. 2015;201:231-236.
    PubMed     Text format     Abstract available


  635. KAJIMOTO K, Sato N, Takano T
    Relation between elevated blood urea nitrogen, clinical features or comorbidities, and clinical outcome in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2015;201:311-314.
    PubMed     Text format    


  636. LU Y, Zhang L, Zhou X, Tang B, et al
    Renal sympathetic denervation: A potential alternative strategy for managing patients with heart failure.
    Int J Cardiol. 2015;201:140-141.
    PubMed     Text format    


  637. GOTZ N, Patzelt J, Seizer P, Walker T, et al
    Percutaneous mitral valve repair (PMVR) in a patient with recurrence of mitral regurgitation 17years after surgical reconstruction.
    Int J Cardiol. 2015;201:321-323.
    PubMed     Text format    


  638. TAKAHASHI M, Kinugawa S, Takada S, Hirabayashi K, et al
    Low-intensity exercise under ischemic conditions enhances metabolic stress in patients with heart failure.
    Int J Cardiol. 2015;201:142-144.
    PubMed     Text format    


    July 2015
  639. TAKEUCHI T, Dohi K, Omori T, Moriwaki K, et al
    Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure.
    Int J Cardiol. 2015;201:1-3.
    PubMed     Text format    


  640. YAMAZOE M, Mizuno A, Niwa K, Isobe M, et al
    Edema index measured by bioelectrical impedance analysis as a predictor of fluid reduction needed to remove clinical congestion in acute heart failure.
    Int J Cardiol. 2015;201:190-192.
    PubMed     Text format    


  641. SAVARESE G, Edner M, Dahlstrom U, Perrone-Filardi P, et al
    Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2015;199:415-423.
    PubMed     Text format     Abstract available


  642. SMOLIS-BAK E, Dabrowski R, Piotrowicz E, Chwyczko T, et al
    Hospital-based and telemonitoring guided home-based training programs: Effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
    Int J Cardiol. 2015;199:442-447.
    PubMed     Text format     Abstract available


  643. PETERS S
    Prognostic value of epsilon waves in lead aVR in arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2015;191:77-8.
    PubMed     Text format    


  644. LAI KB, Sanderson JE, Izzat MB, Yu CM, et al
    Micro-RNA and mRNA myocardial tissue expression in biopsy specimen from patients with heart failure.
    Int J Cardiol. 2015;199:79-83.
    PubMed     Text format     Abstract available


  645. GAYAT E, Caillard A, Laribi S, Mueller C, et al
    Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure.
    Int J Cardiol. 2015;199:241-247.
    PubMed     Text format     Abstract available


  646. MASUDA M, Yamada T, Mizuno H, Minamiguchi H, et al
    Impact of atrial fibrillation ablation on cardiac sympathetic nervous system in patients with and without heart failure.
    Int J Cardiol. 2015;199:65-70.
    PubMed     Text format     Abstract available


  647. CHEN M, Yu L, Sheng X, Liu Q, et al
    Cardiac autonomic tone modulators: Promising feasible options for heart failure with hyper-sympathetic activity.
    Int J Cardiol. 2015;198:185-186.
    PubMed     Text format    


  648. ANTONIOU CK, Chrysohoou C, Lerakis S, Manolakou P, et al
    Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: A comparison of three therapeutic pr
    Int J Cardiol. 2015;199:44-49.
    PubMed     Text format     Abstract available


  649. DANDEL M, Krabatsch T, Falk V
    Left ventricular vs. biventricular mechanical support: Decision making and strategies for avoidance of right heart failure after left ventricular assist device implantation.
    Int J Cardiol. 2015;198:241-250.
    PubMed     Text format     Abstract available


    June 2015
  650. EYUBOGLU M
    How can we detect the low risk patients for ischemic etiology in heart failure population?
    Int J Cardiol. 2015;197:1.
    PubMed     Text format    


  651. WANG X, Peng J, Xie X, Qian J, et al
    Tricuspid regurgitation predicts cardiorenal syndrome in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2015;197:83-84.
    PubMed     Text format    


  652. RADEMAKER MT, Ellmers LJ, Charles CJ, Mark Richards A, et al
    Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine.
    Int J Cardiol. 2015;197:56-65.
    PubMed     Text format     Abstract available


  653. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".
    Int J Cardiol. 2015;189:247-8.
    PubMed     Text format    


  654. KRACHLER B, Savonen K, Komulainen P, Hassinen M, et al
    VO2max/kg is expected to be lower in obese individuals!
    Int J Cardiol. 2015;189:234.
    PubMed     Text format    


  655. RUSHTON CA, Satchithananda DK, Jones PW, Kadam UT, et al
    Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis.
    Int J Cardiol. 2015;196:98-106.
    PubMed     Text format     Abstract available


  656. FARAG M, Mabote T, Shoaib A, Zhang J, et al
    Hydralazine and nitrates alone or combined for the management of chronic heart failure: A systematic review.
    Int J Cardiol. 2015;196:61-69.
    PubMed     Text format     Abstract available


  657. TOPCU S, Aksu U, Tanboga IH, Sevimli S, et al
    Giant left ventricle pseudoaneurysm that caused heart failure.
    Int J Cardiol. 2015;196:34-35.
    PubMed     Text format    


  658. MAKINO J, Kohsaka S, Shiraishi Y, Inohara T, et al
    Application of the United States acute heart failure risk prediction model in Japanese patients; analysis from a contemporary multicenter registry.
    Int J Cardiol. 2015;195:323-325.
    PubMed     Text format    


    May 2015
  659. ALVELOS M, Couto M, Laszczynska O, Almeida PB, et al
    Measuring renal function in acute heart failure: A place for old and new equations.
    Int J Cardiol. 2015;196:70-72.
    PubMed     Text format    


  660. HELSEN F, De Meester P, Van Keer J, Gabriels C, et al
    Pulmonary outflow obstruction protects against heart failure in adults with congenitally corrected transposition of the great arteries.
    Int J Cardiol. 2015;196:1-6.
    PubMed     Text format     Abstract available


  661. LIM HS, Andrianopoulos N, Sugumar H, Stub D, et al
    Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.
    Int J Cardiol. 2015;195:259-264.
    PubMed     Text format     Abstract available


  662. VOLTERRANI M, Iellamo F
    Eplerenone in chronic heart failure with depressed systolic function.
    Int J Cardiol. 2015 May 21. pii: S0167-5273(15)01189.
    PubMed     Text format     Abstract available


  663. SCHOU M, Bosselmann H, Gaborit F, Iversen K, et al
    Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients.
    Int J Cardiol. 2015;195:143-148.
    PubMed     Text format     Abstract available


  664. MA Z, Fang F, Chui KL, Chen T, et al
    A Rare Etiology of Severe Acute Heart Failure: Subacute Spinal Subdural Hematoma in a Young Woman.
    Int J Cardiol. 2015;195:61-63.
    PubMed     Text format    


  665. FREA S, Bovolo V, Pidello S, Canavosio FG, et al
    Clinical and prognostic role of ammonia in advanced decompensated heart failure. The cardio-abdominal syndrome?
    Int J Cardiol. 2015;195:53-60.
    PubMed     Text format     Abstract available


  666. JAGODZINSKI A, Havulinna AS, Appelbaum S, Zeller T, et al
    Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Int J Cardiol. 2015;192:33-39.
    PubMed     Text format     Abstract available


  667. BRUNETTI ND, Correale M, Totaro A, Ferraretti A, et al
    Lower cardiovascular mortality with atorvastatin and rosuvastatin vs simvastatin: Data from "moderate-intensity" statin users in an observational registry on chronic heart failure (Daunia Heart Failure Registry).
    Int J Cardiol. 2015;194:23-27.
    PubMed     Text format    


  668. KATO S, Saito N, Kirigaya H, Gyotoku D, et al
    Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2015;191:314-319.
    PubMed     Text format     Abstract available


  669. KALUZA J, Akesson A, Wolk A
    Long-term processed and unprocessed red meat consumption and risk of heart failure: A prospective cohort study of women.
    Int J Cardiol. 2015;193:42-46.
    PubMed     Text format     Abstract available


  670. AKSU U, Topcu S
    Giant right atrium due to rheumatic tricuspid valve stenosis.
    Int J Cardiol. 2015;193:47-48.
    PubMed     Text format    


  671. AKSU U, Kalkan K
    Pericardial effusion and heart failure.
    Int J Cardiol. 2015;192:21.
    PubMed     Text format    


  672. NTALIANIS A, Kapelios CJ, Kanakakis J, Repasos E, et al
    Prolonged intra-aortic balloon pump support in biventricular heart failure induces right ventricular reverse remodeling.
    Int J Cardiol. 2015;192:3-8.
    PubMed     Text format     Abstract available


  673. SMEETS M, Degryse J, Aertgeerts B, Janssens S, et al
    General practitioners' judgement of chronic heart failure in the oldest old: Insights from the BELFRAIL study.
    Int J Cardiol. 2015;191:120-127.
    PubMed     Text format     Abstract available


  674. KAUFMANN BA, Goetschalckx K, Min SY, Maeder MT, et al
    Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy.
    Int J Cardiol. 2015;191:286-293.
    PubMed     Text format     Abstract available


  675. OH PC, Koh KK, Shin J, Yu J, et al
    Stress-induced cardiomyopathy presented with acute decompensated heart failure.
    Int J Cardiol. 2015;191:114-116.
    PubMed     Text format    


  676. KAJIMOTO K, Sato N, Takano T
    Association of age and baseline systolic blood pressure with outcomes in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2015;191:100-106.
    PubMed     Text format     Abstract available


  677. GUDER G, Stork S
    The role of circulatory power and cardiac reserve in reverse epidemiology - Assessing heart failure severity.
    Int J Cardiol. 2015;191:48-49.
    PubMed     Text format    


  678. SOUZA FC, Neri JS, Marques EB, Barros RB, et al
    Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
    Int J Cardiol. 2015;191:4-6.
    PubMed     Text format    


  679. NIEMINEN MS, Dickstein K, Fonseca C, Serrano JM, et al
    The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations.
    Int J Cardiol. 2015;191:256-264.
    PubMed     Text format     Abstract available


  680. KIRAT T, Kose N
    Response to the letter by Akinori Sairaku et al.: Different mechanisms = synergic effect.
    Int J Cardiol. 2015;186:148.
    PubMed     Text format    


    April 2015
  681. THANG ND, Karlson BW, Sundstrom BW, Karlsson T, et al
    Pre-hospital prediction of death or cardiovascular complications during hospitalisation and death within one year in suspected acute coronary syndrome patients.
    Int J Cardiol. 2015;185:308-12.
    PubMed     Text format     Abstract available


  682. OHLOW MA, von Korn H, Lauer B
    Characteristics and outcome of congenital left ventricular aneurysm and diverticulum: Analysis of 809 cases published since 1816.
    Int J Cardiol. 2015;185:34-45.
    PubMed     Text format     Abstract available


  683. IYISOY A, Ozturk C, Unlu M, Celik T, et al
    Cardiac resynchronization therapy in a patient with percutaneous mitral annuloplasty and prior aortic valve surgery.
    Int J Cardiol. 2015;187:532-533.
    PubMed     Text format    


  684. HUANG B, Yu L, Zhou L, Jiang H, et al
    Renal denervation for the treatment of atrial fibrillation in hypertensive patients or beyond?
    Int J Cardiol. 2015;189:59-60.
    PubMed     Text format    


  685. RAFIQ I, Freeman LJ
    Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'.
    Int J Cardiol. 2015;195:283-284.
    PubMed     Text format    


  686. YILDIZ A, Soydinc S
    Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
    Int J Cardiol. 2015;184:512-3.
    PubMed     Text format    


  687. MORETTI C, Grosso Marra W, D'Ascenzo F, Omede P, et al
    Beta blocker for patients with pulmonary arterial hypertension: A single center experience.
    Int J Cardiol. 2015;184:528-32.
    PubMed     Text format    


  688. PAREEK M, Nielsen ML, Gerke O, Leosdottir M, et al
    Worsening diastolic function is associated with elevated fasting plasma glucose and increased left ventricular mass in a supra-additive fashion in an elderly, healthy, Swedish population.
    Int J Cardiol. 2015;184:466-72.
    PubMed     Text format     Abstract available


  689. EINDHOVEN JA, Roos-Hesselink JW, van den Bosch AE, Kardys I, et al
    High-sensitive troponin-T in adult congenital heart disease.
    Int J Cardiol. 2015;184:405-11.
    PubMed     Text format     Abstract available


  690. OHUCHI H, Negishi J, Hayama Y, Sasaki O, et al
    Hyperuricemia reflects global Fontan pathophysiology and associates with morbidity and mortality in patients after the Fontan operation.
    Int J Cardiol. 2015;184:623-30.
    PubMed     Text format     Abstract available


  691. LUMENS J, Vernooy K
    Better understanding before implanting.
    Int J Cardiol. 2015;184:6-8.
    PubMed     Text format    


    March 2015
  692. ZHU Z, Hu X, Fang Z, Zhou S, et al
    Endothelial cell is critical in HMGB1 mediated cardiac impairment in ischemic heart disease.
    Int J Cardiol. 2015;187:39-40.
    PubMed     Text format    


  693. WHITE JM, Khalique OK, Kodali SK
    Immediate, same-setting paravalvular leak closure following transcatheter aortic valve replacement.
    Int J Cardiol. 2015;189:235-237.
    PubMed     Text format    


  694. YAP LB, Qadir F, Nguyen ST, Ma SK, et al
    The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients.
    Int J Cardiol. 2015;183:178-9.
    PubMed     Text format    


  695. KUSCHYK J, Roeger S, Schneider R, Streitner F, et al
    Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients.
    Int J Cardiol. 2015;183:76-81.
    PubMed     Text format     Abstract available


  696. BARGE-CABALLERO E, Segovia-Cubero J, Gonzalez-Vilchez F, Delgado-Jimenez J, et al
    Evaluation of the preoperative vasoactive-inotropic score as a predictor of postoperative outcomes in patients undergoing heart transplantation.
    Int J Cardiol. 2015;185:192-194.
    PubMed     Text format    


  697. GEREDE DM, Sayin T, Vurgun VK, Akbulut IM, et al
    Dramatic improvement of clinical and hemodynamic parameters of a heart transplant candidate with sildenafil treatment.
    Int J Cardiol. 2015;185:148-149.
    PubMed     Text format    


  698. CIPRIANI M, Ammirati E, Landolina M, Oliva F, et al
    Cumulative analysis on 4802 patients confirming that women benefit more than men from cardiac resynchronization therapy.
    Int J Cardiol. 2015;182:454-6.
    PubMed     Text format    


  699. VON BIBRA H, Paulus WJ, St John Sutton M, Leclerque C, et al
    Quantification of diastolic dysfunction via the age dependence of diastolic function - impact of insulin resistance with and without type 2 diabetes.
    Int J Cardiol. 2015;182:368-74.
    PubMed     Text format     Abstract available


  700. BALLO P, Fantini A, Vannelli P, Fibbi V, et al
    A resynchronized shunt: Biventricular pacing followed by acute clinical decompensation in a patient with misdiagnosed atrial septal defect.
    Int J Cardiol. 2015;182:288-90.
    PubMed     Text format    


  701. LESZEK P, Sochanowicz B, Brzoska K, Danko B, et al
    Does myocardial iron load determine the severity of heart insufficiency?
    Int J Cardiol. 2015;182:191-3.
    PubMed     Text format    


  702. POPPE KK, Whalley GA, Doughty RN, Woodward M, et al
    The development and feasibility of a composite score of echocardiographic indices that may stratify outcome in patients with diabetes mellitus.
    Int J Cardiol. 2015;182:244-9.
    PubMed     Text format     Abstract available


    February 2015
  703. NAKAJIMA M, Takada A, Maeda H, Saito K, et al
    Near-miss of ruptured myocardial infarction and catheter ablation injury associated with lethal cardiac tamponade.
    Int J Cardiol. 2015;201:336-338.
    PubMed     Text format    


  704. HELLENKAMP K, Darius H, Giannitsis E, Erbel R, et al
    The German CPU Registry: Dyspnea independently predicts negative short-term outcome in patients admitted to German Chest Pain Units.
    Int J Cardiol. 2015;181:88-95.
    PubMed     Text format     Abstract available


  705. FINEGOLD J, Bordachar P, Kyriacou A, Sohaib SM, et al
    Atrioventricular delay optimization of cardiac resynchronisation therapy: comparison of non-invasive blood pressure with invasive haemodynamic measures.
    Int J Cardiol. 2015;180:221-2.
    PubMed     Text format    


    January 2015
  706. LATTUCA B, Roubille F
    Ivabradine: a promising drug in cardiogenic shock to prevent the undesirable sinus tachycardia induced by dobutamine?
    Int J Cardiol. 2015;178:308-10.
    PubMed     Text format    


  707. SHIUE I, Perkins DR, Bearman N
    Postprocedural disorders of circulatory system admissions peaked at physically equivalent temperature 0-10 degrees C in Germany in 2009-2011.
    Int J Cardiol. 2015;178:10-1.
    PubMed     Text format    


  708. WANG BH, von Lueder TG, Kompa AR, Huang L, et al
    Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.
    Int J Cardiol. 2015;186:104-5.
    PubMed     Text format    


  709. NAPP LC, Brehm M, Kuhn C, Schafer A, et al
    Heart against veno-arterial ECMO: Competition visualized.
    Int J Cardiol. 2015;187:164-5.
    PubMed     Text format    


  710. RODRIGUEZ Y, Nan J, Yasin O, Gorcsan J 3rd, et al
    The impact of a strategy of image-guided left ventricular lead placement during cardiac resynchronization therapy on health care utilization.
    Int J Cardiol. 2015;187:311-2.
    PubMed     Text format    


  711. TAN DK, Hothi SS, Macdonald W, Schlosshan D, et al
    Impacts of valve intervention on the Functional REServe of the Heart: The FRESH-valve pilot study.
    Int J Cardiol. 2015;187:491-501.
    PubMed     Text format     Abstract available


    December 2014
  712. KORANTZOPOULOS P
    Maneuvers to eliminate loss of biventricular pacing due to T-wave oversensing.
    Int J Cardiol. 2014;177:523.
    PubMed     Text format    


    November 2014
  713. GREVE AM, Bang CN, Berg RM, Egstrup K, et al
    Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: The SEAS study.
    Int J Cardiol. 2014;180C:122-128.
    PubMed     Text format     Abstract available


  714. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Int J Cardiol. 2014;180C:1-5.
    PubMed     Text format     Abstract available


    October 2014
  715. ABUHAB A, Bacal F
    Cost-effectiveness analysis of Chagas' cardiomyopathy: early diagnosis and prevention should be the target for comparison.
    Int J Cardiol. 2014;176:1238.
    PubMed     Text format    


    August 2014
  716. SINGHAL R, Chang SL, Chong E, Hsiao YW, et al
    Colchicine suppresses atrial fibrillation in failing heart.
    Int J Cardiol. 2014 Aug 17. pii: S0167-5273(14)01277.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: